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1ABBREVIATIONS
The abbreviations are according to biochemical nomenclature by IUPAC-IUB
Joint Commission, Eur. J. Biochem., 138, 9 (1984), are used throughout.  Unless
otherwise specified, amino acids without Aib are L-stereoisomers.  Additional
abbreviations are as follows:
Acc: 1-aminocyclopropanecarboxylic acid
Aib: 2-aminoisobutyric acid
L-BAPA: benzoyl-L arginine p-nitroanilide
Boc: t-butyloxycarbonyl
CD: circular dichroism
DCC: dicyclohexylcarbodiimide
DIEA:  N,N-diisopropylethylamine
DMF: N,N-dimethylformamide
DPhPC: diphytanoylphosphatidylcholine
DPPC: dipalmitoylphosphatidylcholine
DPPG: dipalmitoylphosphatidylglycerol
Fmoc: 9-fluorenylmethoxycarbonyl
HBTU: O-benzotriazole-N,N,N’,N’-tetramethyluronium-hexafluorophosphate
HEPES: N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid
HOBt: 1-hydroxybenzotriazole
MALDI-TOF MS:  matrix-assisted laser desorption ionization time-of-flight mass
spectroscopy
2NATA: N-acetyltryptophanamide
NMP: N-methylpyrrolidone
PBS: phosphate-buffered saline
Rink Amide resin: 4-(2, 4-dimethoxyphenyl-Fmoc-aminomethyl)phenoxy resin
RP-HPLC:  reversed phase high-performance liquid chromatography
SUVs: small unilamellar vesicles
TFA:  trifluoroacetic acid
TFE:  trifluoroethanol
Tris: tris(hydroxymethyl)-aminomethane
fh: helical content
G: molar free energy of transfer of the peptide from aqueous phase to the lipid membrane
KI: inhibition constant
Kp: apparent molar partition coefficient
KSV: Stern-Volmer constant
MIC:  minimum inhibitory concentration
t1/2 : half-life
max : emission maximum wavelength
3ABSTRACT
Amino acid residues other than the twenty from which proteins are synthesized
also have important biological functions.  These unusual (non-standard) amino acid
residues result from the specific chemical modifications of amino acid residues or non-
ribosomal systems.  2-Aminoisobutyric a id (Aib) is an unusual amino acid, which is
present in some antimicrobial peptides, peptaibols, isolated from fungi.  Peptaibols forms
self-assembled helical conformations in lipid membranes and exhibit the voltage-
dependent ion channels imilar to ion channel proteins.  In spite of the interesting
properties of peptaibols, a few structure-activity relationship studies of peptaibols have
been so far documented.  This is due to the synthetic difficulties arising from the
pronounced steric hindrance of Aib residues. 
In this study, to explore the role of Aib residues in conformations and biological
activities of channel forming Aib peptides, BKBA-20 and related analogs were designed
and synthesized.  Trp-containing peptides based on the Aib-containing peptide
([W12]BKBA-20) and Ala-containing peptide ([W12]AKAA-20) were synthesized to
elucidate the effect of Aib residues on conformations of channel forming peptides (Chapter
2).   Ala-substituted analogs, BKAA-20, AKBA-20 and AKAA-20 were synthesized, and
compared to the original peptide to investigate the effects of the position of the Aib
residues on conformations and biological activities (Chapter 3 and 4).  The interactions of
peptides with lipid membranes were studied by circular dichroism and fluorescence
measurements.  Biological activities of peptides were evaluated as antimicrobial,
hemolytic and　protease resistance activities.  Moreover, the channel formations of
peptides were investigated by the tip-dip patch-clamp technique.  Consequently, it was
4found that Aib residues in peptides affected the stability of self-associated helical
structures and ion channel structures and the position of Aib residues into peptide
backbone not only promotes the generation of stable helical conformations, but also
modulates the biological activities.  Results of this study can implicate a deeper
understanding of the role of Aib residues in structure-activity relationships of helical pore
forming peptides, which in turn promotes the rational design of effective antimicrobial
peptides.  An overview of the role of Aib residue in peptide backbone is given in Chapter
5.  
5CHAPTER 1
General Introduction
1-1.  Unusual Amino Acids in Protein and Peptide
Amino Acid Derivatives in Protein—The universal genetic code, which is nearly identical
in all known life forms, specifies only the twenty “standard” amino acids.  Nevertheless,
many other amino acids are components of certain proteins (Fig. 1-1).  These “unusual”
(non-standard) amino acids result from the specific modification of an amino acid residue
after the polypeptide chain has been synthesized.  4-Hydroxyproline and 5-hydroxylysine
residues are important structural constituents of the fibrous protein collagen, the most
abundant protein in mammals.  Amino acids of proteins that form complexes with nucleic
acids are often modified.  For example, ribosomal proteins and chromosomal proteins
known as histones may be specifically methylated, acethylated, and/or phosphorylated.
N-Formylmethionine is initially the N-terminal residue of all prokaryotic proteins, but is
usually removed as the protein maturation process.  g -Carboxyglutamic acid is a
constituent of several proteins involved in blood clotting. In most cases, these
modifications are important for the function of the protein. 
D-Amino Acids in Peptide—D-Amino acid residues are components of many of the
relatively short (< 20 residues) bacterial polypeptides that are enzymatically rather than
ribosomally synthesized.  These peptides are perhaps most widely distributed as
constituents of bacterial cell walls, which D-amino acid render less susceptible to attack by
6N
OHH
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O
the peptidases (enzymes that hydrolyze peptide bonds) that many organisms employ to
digest bacterial cell walls. 
4-hydroxyproline 5-hydroxylysine 3-methylhistidine
 -N-methylarginine -N-acetyllysine O-phosphoserine
N-formylmethionine carboxyglutamic
Fig. 1-1. Some unusual amino acid residues that are components of certain proteins.
All of these residues are modified from one of the 20 standard amino acids after
polypeptide chain biosynthesis. 
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7Likewise, D-amino acids are components of many bacterially produced peptide
antibiotics such as valinomycin, gramicidin S, tyrocidine, gramicidin A, and actinomycin D
(Fig. 1-2).  These peptides are produced by fungi and bacteria via a non-ribosomal
mechanism [1].  Gramicidin S and tyrocidine from Bacillus brevis appeared to be
synthesized by large enzymes (gramicidin synthetase) able to form peptide bonds from
thiol-linked amino acids in a way which resembles fatty acid synthesis [2]. 
valinomycin
gramicidin S
tyrocidine A actinomycin D
Fig. 1-2. Primary structures of some of the D-amino acid containing peptide antibiotics.
Peptides are synthesized by fungi and bacteria via a non-ribosomal mechanism. 
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82-aminoisobutyric acid isovaline 1-aminocyclopropane-
carboxylic acid
dehydroalanine  N-methyl-asparagine t-leucine
Fig. 1-3. Some unusual amino acid residues in peptides that isolated from plants and
fungi.  These residues are introduced into peptide backbone by a non-ribosomal system
of biosynthesis. 
1-2.  2-Aminoisobutyric Acid (Aib)
About 250 different amino acid residues have been found in various plants and
fungi (several residues shown in Fig. 1-3).  These residues are introduced into peptide
backbones by non-ribosomal systems [26].  These biosynthesis systems are different from
the systems for these of unusual amino acid residues in Section 1-1.  Moreover, the
biological activities of these amino acids or residues remain unclear. 
a , a -Dialkyl amino acid has a unique structure (without asymmetric carbon).  2-
Aminoisobutyric acid (Aib) and 1-aminocyclopropanecarboxylic acid (Acc) are the most
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9simple a , a -dialkyl amino acids.  These amino acids are present in peptaibols [3] and a
hormone involved in the ripening of fruit [4], respectively.  Aib is a a , a -dialkyl amino
acid that has been widely investigated (Table 1-1).  Interestingly, Aib was synthesized
before identification of peptaibols [39].  The important property of the Aib residue in the
peptide backbone is the induction of conformational restriction.  The presence of an
additional methyl group on the Ca of Aib restricts the backbone conformational space to (,
) ca.± (57˚, 47˚).  Consequently, Aib is strongly helicogenic, as shown by its ability to
stabilize 310- and a -helical motifs [5-7] (Fig. 1-4).  310- and a -helical conformations are
the two common helical structures manifested in proteins [25]. First Aib-containing
peptide (homo pentapeptide) synthesis was reported in 1960 [40].  However, only a few
reports have been dedicated to the Aib-peptide synthesis, due to th  difficulties arising
from the pronounced steric hindrance caused by a , a -dialkyl amino acid. In 1981,
synthesis of peptaibols was achieved by solution-phase method using new carboxyl-
activating regents [41].  Solid-phase synthesis was finally reported in 1995 [42]. 
Table 1-1.  History of Aib study
year study
1872 chemical synthesis
1958 identification from peptaibol
1960 peptide synthesis homo pentapeptide
1970 Ramachandran plot helix conformation
1977 X-ray study helix conformation
1981 peptaibol synthesis solution-phase synthesis
1982 function of peptaibol ion channel activity
1995 peptaibol synthesis solid-phase synthesis
10
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Fig. 1-4. Structure and dihedral angles of Aib and Ramachandran plot. 
1-3.  The Peptaibol Family
Structure—Peptaibols (peptide with Aib and C-terminal amino alcohol) generally exhibit
antimicrobial activity and are referred to as antibiotic peptides.  The main sources of the
peptaibols known to date are fungi of the genre Trichoderma and Emericellopsis.  Over
200 peptaibol sequences have been reported to date (http://www.cryst.bbk.ac.uk/peptaibol),
because of development of analytical instruments such as HPLC and mass spectroscopy.
Several peptaibols, each containing 20 amino acid residues, are presented in Fig. 1-5.
Three structural characteristics define the family of peptides known as peptaibols:
(1) A short chain-length, typically between 15- and 20 residues, although shorter chain
lengths are also known (5 residues).
(2) High proportions of the amino acid residues are unusual amino acids, especially Aib.
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(3) The chains have an alkyl N terminus (usually acetyl) and a hydroxy-amino acid (2-
amino alcohol) at their C terminus.
Along with Aib, unusual amino acid residues that have been observed include isovaline
(Iva), hydroxyproline (Hyp) and ethylnorvaline (Etnor).  Aib residue has a high tendency
to form helices (Section 1-2) and this evident from the helical structures of the peptaibols.
The biosynthesis of peptaibols requires novel pathways, such as the biosynthesis of
gramicidin S (Section 1-1), to produce and incorporate these unusual amino acids.
Apparently, peptaibols’ biosynthesis initiated by acetyl transfer to thioester-activated
aminoisobutyrate (non-ribosomal system) [12].  Therefore, peptaibols have many
homologs (Fig. 1-5). 
Biological Activity—Peptaibols generally form ion channel in membranes.  Despite their
small size, they display a rich variety of channel behaviors including ion selectivity,
voltage dependence, subconductance states and blocking and modulation of channel
properties [35-37].  Ion channel formation in peptaibols (1) is an essential part of their
antimicrobial activity [14].  The channels (pores) are able to conduct ionic species; this
conductance leads to the loss of osmotic balance and cell death.  Other activities are (2)
the uncoupling of oxidative phosphorylation i rat liver mitochondria [15]; (3) the
induction of catecholamine s cretion in bovine adrenal chromaffin cells [16]; and (4)
acting as elicitors in some plants [17, 18].  These activities a can be also caused by the ion
influx into the organelles or the cells through the peptaibol channels.  However, these
detailed mechanisms remain unclear. 
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Alamethicin F-30 Ac- B-P- B-A- B-A-Q- B-V- B-G-L- B-P-V- B- B-E-Q-F-OL
Alamethicin F-50 Ac- B-P- B-A- B-A-Q- B-V- B-G-L- B-P-V- B- B-Q-Q-F-OL
Alamethicin II Ac- B-P- B-A- B- B-Q- B-V- B-G-L- B-P-V- B- B-E-Q-F-OL
Atroviridin A Ac- B-P- B-A- B-A-Q- B-V- B-G-L- B-P-V- B- B-Q-Q-F-OL
Atroviridin B Ac- B-P- B-A- B-A-Q- B-V- B-G-L- B-P-V- B- J -Q-Q-F-OL
Atroviridin C Ac- B-P- B-A- B- B-Q- B-V- B-G-L- B-P-V- B- J -Q-Q-F-OL
Hypelcin A Ac- B-P- B-A- B- B-Q-L- B-G- B- B- B-P-V- B- B-Q-Q-L-OL
Hypelcin A-I Ac- B-P- B-A- B- B-Q- B-L- B-G- B- B-P-V- B- B-Q-Q-L-OL
Hypelcin A-II Ac- B-P- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- B-Q-Q-L-OL
Hypelcin A-III Ac- B-P- B-A- B- B-Q- B-L- B-G- B- B-P-V- B- B-Q-Q-C 7H16NO
Hypelcin A-IV Ac- B-P- B-A- B- B-Q- B-I- B-G- B- B-P-V- B- B-Q-Q-L-OL
Hypelcin A-III Ac- B-P- B-A- B- B-Q- B-L- B-G- B- B-P-V- B- J -Q-Q-L-OL
Hypelcin A-IX Ac- B-P- B-A- B- B-Q- B-I- B-G- B- B-P-V- B- J -Q-Q-L-OL
Hypelcin A-V Ac- B-P- B-A- B- B-Q- B-L- B-G- B- B-P-V- B- B-Q-Q-I-OL
Hypelcin A-VI Ac- B-P- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- B-Q-Q-I-OL
Hypelcin A-VII Ac- B-P- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- J -Q-Q-L-OL
Hypelcin A-VIII Ac- B-P- B-A- B-A-Q- B-I- B-G- B- B-P-V- B- B-Q-Q-L-OL
Hypelcin B-I Ac- B-P- B-A- B- B-Q- B-L- B-G- B- B-P-V- B- B-E-Q-L-OL
Hypelcin B-II Ac- B-P- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- B-E-Q-L-OL
Hypelcin B-III Ac- B-P- B-A- B- B-Q- B-L- B-G- B- B-P-V- B- J -E-Q-L-OL
Hypelcin B-IV Ac- B-P- B-A- B- B-Q- B-I- B-G- B- B-P-V- B- B-E-Q-L-OL
Hypelcin B-V Ac- B-P- B-A- B- B-Q- B-L- B-G- B- B-P-V- B- B-E-Q-I-OL
Longhibrachin A-I Ac- B-A- B-A- B-A-Q- B-V- B-G-L- B-P-V- B- B-Q-Q-F-OL
Longhibrachin A-II Ac- B-A- B-A- B-A-Q- B-V- B-G-L- B-P-V- B- J -Q-Q-F-OL
Longhibrachin A-III Ac- B-A- B-A- B- B-Q- B-V- B-G-L- B-P-V- B- B-Q-Q-F-OL
Longhibrachin A-IV Ac- B-A- B-A- B- B-Q- B-V- B-G-L- B-P-V- B- J -Q-Q-F-OL
Longhibrachin B-II Ac- B-A- B-A- B-A-Q- B-V- B-G-L- B-P-V- B- B-E-Q-F-OL
Longhibrachin B-III Ac- B-A- B-A- B-A-Q- B-V- B-G-L- B-P-V- B- J -E-Q-F-OL
Paracelsin A Ac- B-A- B-A- B-A-Q- B-V- B-G- B- B-P-V- B- B-Q-Q-F-OL
Paracelsin B Ac- B-A- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- B-Q-Q-F-OL
Paracelsin C Ac- B-A- B-A- B- B-Q- B-V- B-G- B- B-P-V- B- B-Q-Q-F-OL
Paracelsin D Ac- B-A- B-A- B- B-Q- B-L- B-G- B- B-P-V- B- B-Q-Q-F-OL
Paracelsin E Ac- B-A- B-A- B-A-Q- B-L- B-G- B-A-P-V- B- B-Q-Q-F-OL
Polysporin A Ac- B-P- B-A- B- B-Q- B-V- B-G-V- B-P-V- B- B-Q-Q-F-OL
Polysporin B Ac- B-P- B-A- B- B-Q- B-V- B-G-L- B-P-V- B- B-Q-Q-F-OL
Polysporin C Ac- B-P- B-A- B- B-Q- B-I- B-G-L- B-P-V- B- B-Q-Q-F-OL
Polysporin D Ac- B-P- B-A- B- B-Q- B-I- B-G-L- B-P-V- B-V-Q-Q-F-OL
Suzukacillin Ac- B-A- B-A- B-A-Q- B- B- B-G-L- B-P-V- B- B-Q-Q-F-OL
Trichocellin TC A-I Ac- B-A- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- B-Q-Q-F-OL
Trichocellin TC-A-II Ac- B-A- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- J -Q-Q-F-OL
Trichocellin TC-A-III Ac- B-A- B-A- B-A-Q- B-I- B-G- B- B-P-V- B- B-Q-Q-F-OL
Trichocellin TC-A-IV Ac- B-A- B-A- B-A-Q- B-I- B-G- B- B-P-V- B- J -Q-Q-F-OL
Trichocellin TC-A-V Ac- B-A- B-A- B-A-Q- B-L- B-G-L- B-P-V- B- B-Q-Q-F-OL
Trichocellin TC-A-VI Ac- B-A- B-A- B-A-Q- B-L- B-G-L- B-P-V- B- J -Q-Q-F-OL
Trichocellin TC-A-VII Ac- B-A- B-A- B-A-Q- B-I- B-G-L- B-P-V- B- B-Q-Q-F-OL
Trichocellin TC-A-VIII Ac- B-A- B-A- B-A-Q- B-I- B-G-L- B-P-V- B- J -Q-Q-F-OL
Trichocellin TC-B-I Ac- B-A- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- B-E-Q-F-OL
Trichocellin TC-B-II Ac- B-A- B-A- B-A-Q- B-L- B-G- B- B-P-V- B- J -E-Q-F-OL
Fig. 1-5. Several primary structures of peptaibols (20 residues) [ref 13].  Amino acid
is presented by one letter code. B and J are Aib and Iva (isovaline), respectively. 
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1-4.  Alamethicin
Structure—Alamethicin (Fig. 1-5), isolated from the fungi Trichoderma viride, has been
so far the most intensively studied peptaibols.  Alamethicin adopts a largely a -helical
structure in phospholipid membranes [8, 19] and in its crystal structure [20]. Overall, the
peptide is quite hydrophobic, but its crystal structure displays a weak laterally amphipathic
character with two Gln residues lying on one face of the helix.  (Amphipathic character is
a common feature in naturally occurring non-Aib containing antimicrobial peptides, which
is considered to be one of the important factors in antimicrobial activity [21-23]). 
Ion Channel Formation—A characteristic property of alamethicin is its ability to form
well-resolved voltage-dependent, multi-state conducting and weak cation-selective channel
in membranes (Fig. 1-6).  The widely accepted channel model is the so-called barrel-stave
model (Fig. 1-7) [24]. According to this model the alamethicin channel is built by a
bundle of helical monomers forming a water-filled transmembrane pore th ough which
ions can cross lipid membranes.  An association of different numbers of helical
monomers is suggested to determine the multiple conductance levels.  Moreov r, the pore
is lined by polar residues (because of alamethicin forms amphipathic helix in membranes),
and is therefore potentially available to interact with water molecules and ions. The
exposed carbonyl oxygen of Gly11 is considered to be responsible for the weak cation
selectivity of the pore.  In addition, it is proposed that each of the side chains of Gln7 form
hydrogen bond each other, generating a hydrogen-bonded annulus within the channel (Fig.
1-7). This hydrogen-bonded annulus would serve to stabilize the channel structure. 
14
Fig. 1-6.  Conductance pattern of alamethicin in DPhPC bilayers at a cis
transmembrane potential of 120 mV.  The electrolyte solution was composed of 0.5 M
KCl buffered with HEPES at pH 7.4; electrolyte composition was symmetrical for both
sides of the membrane, alamethicin (100 nM) was added to the cis side solution.  
  Sansom, M.S.P. (1993) Q. Rev. Biophys. 26,365–421.
Fig. 1-7. Barrel-stave model (left) and structure (right) of alamethicin channel. 
closed
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level 2
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1-5.  Aims of the Present Study
As described above, alamethicin and some peptaibols form ion channels that may
be more closely related to full-size channel proteins. Therefore, these peptides have been
studies widely as models for ion channel proteins [27-33].  Molle et al. have reported
structure-activity relationships of an alamethicin analog in which all Aib residues were
replaced by Leu residues [28-30].  This analog showed similar properties to those of
alamethicin, but the channels formed appear to be significantly less stable than those
formed by alamethicin [28].  Moreover, peptaibols (alamethicin, ampullosporin A,
bergofungious and chrysospermin A) represent a novel and powerful class of elicitors that
can induce multiple metabolic activities such as ethylene emission, biosynthesis of volatile
substances, and tendril coiling [17, 18]. In contrast, similar channel-forming peptides
(non Aib-containing peptides), melittin and valinomycin, has no metabolic activity [17].
These results are of great interest for further exploration of the role of Aib in different
types of biological activity. 
Until lately, Aib-containing peptides were more difficult to synthesize than non
Aib-containing peptides, because of difficulties arising from the pronounced steric
hindrance caused a , a -dialkyl amino acids (incomplete coupling, racemization due to slow
coupling to hindered amino acids, etc.). Studies of conformational nalysis and the
structure-functional relationships of the biologically active peptides using Aib-containing
peptides have been previously carried out.  However, these peptides were short chain-
length (< 10 residues) or possessed low proportions (1 or 2) of Aib residue(s) [6, 9-11 and
38]. Consequently, the structure-function relationship of peptaibols has been studied with
a focus on natural products as the main source.  In a ecent study, we have successfully
16
synthesized Aib-containing peptides, with long chain-length and high proportions of Aib
(content: 50 %), using an improved Fmoc-chemistry method in our laboratory [34]. 
In this work, to explore the role of Aib residues in conformations and biological
activities of channel forming Aib peptides, Ac-(Aib-Lys-Aib-Ala)5-NH2 (BKBA-20) and
its related analogs were designed and synthesized.  In Chapter 2, Trp-containing peptides
based on the Aib-containing peptide ([W12]BKBA-20) and Ala-containing peptide
([W12]AKAA-20) were synthesized to elucidate the effect of Aib residues on the
conformations of channel forming peptide in phospholipid membranes. In Chapter 3 and
4, Ala-substituted analogs, BKAA-20, AKBA-20 and AKAA-20 were synthesized, and
compared to the original peptide to investigate the effects of the position of the Aib
residues on peptide conformations and biological activities.  The int ractions of peptides
with lipid membranes were studied by CD and fluorescence spectroscopy measurements.
Biological activities of peptides were evaluated as antimicrobial, hemolytic and protease
resistance activities.  In addition, the channel formations of peptides were investigated by
the tip-dip patch-clamp technique. 
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CHAPTER 2
Interactions of Channel Forming Aib-Peptides with
Phospholipid Membranes
2-1. Summary
2-Aminoisobutyric a id (Aib) residue is a characteristic residue that occurs in
peptide antibiotics, peptaibols.  A synthetic Aib-containing peptide, BKBA-20, exhibited
well-defined ion channels in diphytanoylphosphatidylcholine bilayers.  In contrast, Ala-
containing peptide, AKAA-20
 
did not form the channels.  To explore the interactions of
the peptides with phospholipid membranes in detail, we synthesized two Trp-containing
peptides based on the Aib-containing peptide, [W12]BKBA-20 and Ala-containing peptide,
[W12]AKAA-20.  Circular dichroism spectra are showed that [W12]BKBA-20 and
[W12]AKAA-20 prefer to form comparable helical structure in neutral and acidic
phospholipid membranes.  The fluorescence quenching studies of Trp residue revealed
that [W12]BKBA-20 was deeply buried in the hydrophobic region of lipid membranes as
compared to [W12]AKAA-20.  Moreover, [W12]BKBA-20 had a high affinity with
phospholipid membranes.  Results of this study indicated that the Aib residues in channel
peptides are contributed to the stability of self-associated helical structures and the high
affinity with phospholipid membranes.  Aib-containing peptides with an appropriate
sequence can penetrate the membrane and produce stable ion channel-forming structures. 
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2-2. Introduction
Ion channels are important in mediation of the transmembrane transduction of
electrical signals between cells and cellular compartments [1].  The sizes (molecular
weight) of natural ion channels are very broad range.  It is known that several peptide
antibiotics interact with biological membranes and then form ion channels [2-8].
Alamethicin (F-30: Ac-BPBABAQBVBGLBPVBBEQF-ol)  comprises a family of
peptaibol (peptide with Aib and C-terminal amino alcohol) and is isolated from
Trichoderma viride, which contains a high proportion of the unusual amino acid, 2-
aminoisobutyric acid (Aib) [2, 3].  Alamethicin and other peptaibols form ion channels,
which may be more closely related to full-size channel proteins.  Therefore, these
peptides have been studies widely in order to insight into the mechanism of channel
formation [4-8]. However, the structure-function relationship of peptaibols has been
studied with the focus on natural products as the main source [9-15], because of Aib-
containing peptides are more difficult to synthesize than non Aib-containing peptides. 
We have previously reported the successfully synthesis and properties of a series
of Aib-containing peptides, Ac-(Aib-Lys-Aib-Ala)n-NH2 (n = 1-5) [16]. The longest
peptide, Ac-(Aib-Lys-Aib-Ala)5-NH2 (BKBA-20), takes highly helical structures in
phosphate buffer, trifluoroethanol and dipalmitoylphosphatidylcholine (DPPC) vesicles.
In addition, BKBA-20 exhibited well-defined ion channels with long lifetimes at relatively
low transbilayer potentials and peptide concentrations in diphytanoylphosphatidylcholine
bilayers [16]. In order to compare Aib residues with Ala residues, an Ala-containing
peptide, Ac-(Ala-Lys-Ala-Ala)5-NH2 (AKAA-20) was also synthesized.  AKAA-20 was
not exhibited visible ion channels [ref 17 and Chapter 3]. 
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In this study, to explore the peptide conformations and properties of interactions
of the peptides with phospholipid membranes in details, we synthesized two Trp-
containing peptides based on the Aib-containing peptide, [W12]BKBA-20 and Ala-
containing peptide, [W12]AKAA-20.  The secondary structures of peptides and the
fluorescence of Trp residues were studied by circular dichroism (CD) and fluorescence
measurements, respectively.  Consequently, the Aib-containing peptide forms self-
associate stable helical structures and strongly interacts with phospholipid membranes
compared to the Ala-containing peptide. 
Ac-BKBA-BKBA-BKBW-BKBA-BKBA-NH2 [W
12]BKBA-20
Ac-AKAA-AKAA-AKAW-AKAA-AKAA-NH2 [W
12]AKAA-20
   tryptophan (Trp)
Fig. 2-1. Primary structures (up) of peptides and the helical wheel diagram of BKBA-
20 (down) assuming that peptide are completely helical structure.  [W12]BKBA-20 is
replacement of Ala12 residue by Trp residue (down right).  Aib residue is represented by
B.  
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2-3. Results
Peptide Design—The fluorescence mission spectrum of tryptophan (Trp) is highly
sensitive to its microenvironment [18-23].  As shown in the helical wheel diagram (Fig.
2-1), BKBA-20 have amphipathic character with the hydrophobic region on one side and
the hydrophilic region on the opposite side of the peptide helix. A Trp residue was
introduced in the hydrophobic region (12th position) of amphiphathic helical structure to
monitor peptide-lipid interactions by means of the Trp fluorescence.  It was confirmed by
measurements of CD spectra nd antimicrobial ctivities that Trp introduction did not
affect the structures and activities of original peptides, BKBA-20 and AKAA-20 (data not
shown). 
Conformation of Peptide—The secondary structures of peptides in various environments
were studied by CD spectroscopy.  The helical contents (fh) of peptides were calculated
according to the Sreerama and Woody method [24].  Figure 2-2 shows CD spectra of
peptides in 50 mM phosphate buffer (pH 7.4), the neutral phospholipid DPPC and the
negatively charged phospholipid DPPC/DPPG (dipalmitoylphosphatidylglycerol) (3:1
SUVs (small unilamellar vesicles).  DPPC and DPPC/DPPG liposomes were used as
models for mammalian erythrocyte and bacterial exterior cell membranes, respectively.
Both peptides exhibited helical structures with low helical contents (about 30 %) in buffer.
[W12]BKBA-20 in excessive DPPC and DPPC/DPPG SUVs exhibited comparable helical
structures with typical double minimum bands at 208 and 225 nm and a strong positive
band at 194 nm (fh = 85 %, Fig. 2-2a).  [W
12]AKAA-20 also showed helical structures in
lipid membranes, however, helical contents in DPPC and DPPC/DPPG SUVs were 65 and
80 %, respectively (Fig. 2-2b).  It is suggested that electrostatic interactions between basic
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side-chain of peptide and acidic phosphate group of lipid contribute to these differences.
In addition, the spectra of [W12]BKBA-20 show a red shift than these of [W12]AKAA-20.
Woolley and Wallace reported in their CD studies of interactions of alamethicin in
membranes that the red shift of spectrum can be a sign of peptide aggregation i
membranes [25]. Moreover, in their CD studies in two-stranded a -helical coiled-coil
peptides, Hodges et al. reported that CD spectrum represents the peptide aggregation once
the ratio of [q] n-p */[q] p-p * > 1 [26]. From our CD studies, [W
12]BKBA-20 showed [q] n-
p */[q] p-p * =  1.13. In contrast, [W
12]AKAA-20 exhibited [q] n-p */[q] p-p * < 1.  From these
results, [W12]BKBA-20 could form the self-associate species leading to ion channels
formation in lipid membranes. 
Binding Affinity—To evaluate the binding affinity of these peptides for lipid membranes,
the apparent molar partition coefficients (Kp) were determined using CD spectra by the
titration method in which the lipid concentration is varied at constant peptide concentration
[35]. Figure 2-3 shows that the mean residue ellipticity at around 222 nm ([q] n-p *) of each
peptide increased in a sigmoidal manner with increasing lipid concentrations, showing the
amount of helical contents increased with enhancing membrane-bound peptide.  And each
peptide was mostly bound at lipid concentrations of about 1 mM or less (lipid to peptide
molar ratio £  100). The isodichroic points were observed around 202 nm, emonstrating
that in buffer with various lipid concentrations there were primarily two populations of
these peptides, a simple two-state model (free peptide in buffer and membrane-bound
peptide) (spectra not shown).  The solid lines in Fig. 2-3 represent fits to the CD data
made using eq 1 with Kp and [q ]max as a fitting parameters [35] and are given in Table 2-1.
The estimated Kp values of [W
12]BKBA-20 in DPPC and DPPC/DPPG were 4.71 ´  105 and
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5.90 ´  105, respectively.  For [W12]AKAA-20, the values of Kp were 2.72 ´  10
5 and 1.69 ´
105 for DPPC and DPPC/DPPG, respectively.  The binding affinities of [W12]BKBA-20
have 2 to 4 times higher than these of [W12]AKAA-20.  The slight differences in binding
affinities between DPPC and DPPC/DPPG were observed, suggesting that the hydrophobic
interaction is predominantly when the peptides interact with phospholipid membranes.
The Kp in the 10
5 range is also observed for amphiphilic transmembrane peptides [36-38].
From these Kp values, the molar free energy (D G) of transfer of the peptides from aqueous
phase to the lipid membranes were obtained using D G = -  RT ln Kp.  The D G of both two
peptides were between - 7.0 and - 7.7 kcal/mol (Table 2-1). 
Table 2-1.  The apparent molar partition coefficients (Kp) and the free energy (G) of
transfer of peptides from water to different lipid membranes at 20 ˚C
peptides lipid Kp ´  10
5 b) D G (kcal/mol) c)
[W12]BKBA-20 DPPC 4.71 ±  1.13 - 7.6
DPPC/DPPG (3:1) a) 5.90 ±  1.47 - 7.7
[W12]AKAA-20 DPPC 2.72 ±  1.03 - 7.3
DPPC/DPPG (3:1) a) 1.69 ±  0.50 - 7.0
a) Molar ratio of DPPC:DPPG was 3:1.  Concentration of peptide was 10 M.  b) Kp =
([P]lipid/[L]) / ([P]water/[W]), where [P]lipid, [L], [P]water and [W] are the molar
concentrations of bound peptide, lipid, free peptide and water, respectively.  c) G were
calculated using G =  RT ln Kp.
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Fig. 2-2. CD spectra of [W12]BKBA-20 (a) and [W12]AKAA-20 (b) in 50 mM phosphate
buffer (pH 7.4), DPPC SUVs and DPPC/DPPG (3/1) SUVs. Concentrations of peptide
and lipid were 10 M and 1 mM, respectively.  Spectra were measured at 20 ˚C. 
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Fig. 2-3.  Association of [W12]BKBA-20 and [W12]AKAA-20 with DPPC SUVs and
DPPC/DPPG (3/1) SUVs.  Mean residue ellipticity at 225 nm ([W12]BKBA-20) and at
222 nm ([W12]AKAA-20) plotted as a function of lipid concentration.  The solid lines are
fits made using eq 1 (see Experimental Procedures).  Conc ntration of peptide was 10
M.  Spectra were measured at 20 ˚C.  Symbols: open circles, [W12]BKBA-20 in DPPC;
open triangles, [W12]AKAA-20 in DPPC; closed circles, [W12]BKBA-20 in DPPC/DPPG;
closed triangles, [W12]AKAA-20 in DPPC/DPPG. 
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Fluorescence Emission Spectra—In order to further investigate the interactions of
peptides with lipid membranes, the fluorescence measurements of Trp residues were
carried out.  Figure 2-4 shows emission spectra of peptides in buffer, DPPC and
DPPC/DPPG (3:1) SUVs.  N-acetyltryptophanamide (NATA), a model compound for
exposed Trp in peptides and proteins, was used as reference compound.  The emission
maximum wavelength values (max) are summarized in Table 2-2.  In buffer, max of both
peptides were around 355 nm.  These values are similar to that of NATA, indicating that
Trp residues of these peptides are exposed to aqueous solutions.  In DPPC and
DPPC/DPPG (3:1) SUVs, emission spectra of peptides showed a blue shift with increasing
intensity.  [W12]BKBA-20 exhibited the same spectra in the neutral and acidic SUVs (Fig.
2-4a). Spectrum of [W12]AKAA-20 in acidic SUVs (max 338 nm) was more intense than
that in neutral SUVs (Fig. 2-4b and Table 2-2).  These max shifts with increasing
intensities were correlated with the helical contents in CD studies (Fig. 2-2).  Generally,
the addition of the liposomes caused a blue shift and fluorescence intensity enhancement
indicating that the fluorephore, e.g. Trp, is buried in a hydrophobic environment of the
membranes [27].  Therefore, [W12]BKBA-20 was located in a more hydrophobic
environment of membranes with forming a -helical conformations compared to
[W12]AKAA-20.  Moreover, the max was used to estimate the position of Trp residue
within the bilayer.  To do this, the max of membrane-bound peptides was compared to the
previously reported standard curve for the dependence of Trp max up n depth within the
bilayer [43] (by considering the acyl chain length of lipid (palmitoyl) and position of Trp
residues in [W12]BKBA-20 and [W12]AKAA-20).  As a results, it is suggested that
[W12]BKBA-20 took transmembrane orientations if the peptide inserted from N-terminal,
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while [W12]AKAA-20 located the surface of the membranes, whether DPPC or
DPPC/DPPG. 
Fluorescence Quenching—To conform the location of [W12]BKBA-20 and [W12]AKAA-
20 in lipid membranes, fluorescence quenching experiments of Trp residues were carried
out. Iodide ion and acrylamide were used as quencher of Trp residue fluorescence.
Fluorescence quenching data were analyzed according to the Stern-Volmer equation.  In
this plot, lower values for the slope of the curve imply that Trp residue is located in a more
hydrophobic region of membranes.  Iodide ion is considered to have access to Trp residue
of membrane surface, whereas acrylamide has good access to the most highly buried Trp
residue in lipid membranes [28].  
Figure 2-5a shows the Stern-Volmer plots of the quenching of Trp fluorescence by
iodide ion.  The plots are linear and Stern-Volmer constant(KSV) values analyzed by the
Stern-Volmer equation (eq 2) are summarized in Table 2-3.  The KSV values of both
peptides in buffer were almost same with these of NATA (12.2 M–1).  On the other hand,
in neutral and acidic SUVs, compared with buffer, KSV values of both peptides were
smaller, indicating that Trp residues in both peptides were shielded from aqueous
environment in lipid membranes.  The KSV values of [W
12]BKBA-20 were smaller than
these of [W12]AKAA-20 in both lipid systems of DPPC and DPPC/DPPG (Table 2-3). 
For acrylamide quenching experiments, similar manners were observed as shown
for iodide ion.  The Stern-Volmer plots by acrylamide exhibited upward curving lines (Fig.
2-5b), indicating that Trp residues were quenched by dynamic and static mechanisms [27].
Therefore, the fluorescence quenching data were evaluated according to the modified
Stern-Volmer equation (eq 3) [29].  In buffer, the KSV values of peptides were comparable
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values to NATA (17.3 M–1).  In both neutral and acidic lipid membranes, the KSV valu s of
[W12]BKBA-20 were also smaller compare to these of [W12]AKAA-20 (Table 2-3), in spite
of acrylamide fficient quencher of highly buried Trp residue than iodide. These
quenching data suggested that Trp residue of [W12]BKBA-20 was buried deeper than that
of [W12]AKAA-20 in the hydrophobic region of lipid membranes. 
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Fig. 2-4. Fluorescence emission spectra of [W12]BKBA-20 (a) and [W12]AKAA-20 (b)
in 50 mM phosphate buffer (pH 7.4), DPPC SUVs and DPPC/DPPG (3/1) SUVs.
Concentrations of peptide and lipid were 3 and 900 M, respectively.  Excitation
wavelength was 280 nm. Spectra were measured at 20 ˚C. 
Table 2-2. Maximum Emission Wavelengths (max) of Peptides in Lipid Membranes
max (nm) 
a)
peptides phosphate buffer DPPC SUVs DPPC/DPPGb) SUVs
[W12]BKBA-20 356 334 333
[W12]AKAA-20 355 341 338
NATA 355 N.D. b) N.D. b)
a) Fluorescence spectra were measured at 20 ˚C and excitation was 280 nm.  b) Molar
ratio of DPPC:DPPG was 3:1.  Concentrations of peptide and lipid were 3 and 900 M,
respectively.  b) not determined. 
DPPC/DPPG
DPPC           
buffer           
450400350300
0
100
200
300
400
500
Wavelength / nm
Fl
u
o
re
sc
e
n
ce
 i
n
te
n
si
ty
450400350300
a
DPPC/DPPG
DPPC           
buffer           
b
32
Fig. 2-5.  Stern-Volmer plots of fluorescence quenching of [W12]BKBA-20 and
[W12]AKAA-20 by iodide ion (a) and acrylamide (b) in DPPC SUVs and DPPC/DPPG
(3/1) SUVs at 20 ˚C.  Concentrations of NATA, peptide and lipid were 3, 3 and 600 M,
respectively.  Excitation wavelength was 295 nm.
Table 2-3.  The Stern-Volmer Constants (KSV) of Peptides in Lipid Membranes
KSV (M
-1) a)
peptides phosphate buffer DPPC SUVs DPPC/DPPG SUVs
KI acrylamide KI acrylamide KI acrylamide
[W12]BKBA-20 12.2 14.1 1.7  3.6 0.5 3.9
[W12]AKAA-20 12.2 13.1 4.6 10.5 1.2 4.5
a) The KSV were determined by the Stern-Volmer equations (see text and Experimental
Procedures).  Excitation wavelength was 295 nm in order to minimize absorptive
screening by the quencher. 
[Quencher] / mM
F
0/
F
0
2
4
6
8
10
200150100500
b
NATA
WA-20 in DPPC
WB-20 in DPPC
WA-20 in DPPC:DPPG
WB-20 in DPPC:DPPG
200150100500
0
1
2
3
4
5
6
a
NATA
WA-20 in DPPC
WB-20 in DPPC
WA-20 in DPPC:DPPG
WB-20 in DPPC:DPPG
33
2-4. Discussion
BKBA-20, highly Aib-containing amphipathic helical peptide, exhibited well-
defined ion channels in diphytanoylphosphatidylcholine bilayers [ref 16, 41 and Chapter 3].
An Ala-containing peptide, Ac-(Ala-Lys-Ala-Ala)5-NH2 (AKAA-20) was also synthesized
in order to compare Aib residues with Ala residues that are the helix-favoring amino acid
in 20 protein amino acids, however, AKAA-20 was not exhibited ion channels [ref 17 and
Chapter 3].  In this study, we synthesized two Trp-containing peptides based on the
channel forming Aib-peptide, [W12]BKBA-20 and non-channel forming Ala-peptide,
[W12]AKAA-20 to explore the peptide conformations and properties of interactions of the
peptides with phospholipid membranes using CD and fluorescence measurements.
Ion Channel Formation of Aib-containing Peptide¾ Various models have been so far
proposed for the mechanisms of channel forming peptides.  The barrel-stave model is a
bundle of amphipathic helical monomers with their polar faces oriented toward the central
aqueous pore and can well explain the alamethicin channel [2-4, 30], wormhole structures
that are formed by a complex of transmembrane h lical peptides and phospholipid
membranes [39], and a detergent-like action of amphipathic helical peptides that disrupts
the bilayer structure locally or on a large scale [32]. Magainins and cecropins that
explained by the later two models exhibit a strong membrane permeabilization (leakage
ability), however, electrophysiological single channel recordings are difficult to perform.
In contrast, BKBA-20 exhibited comparable structures as alamethicin in phospholipid
membranes and weak leakage ability toward lipid membranes, and BKBA-20 formed well-
defined ion channels [16].  Thus, the barrel-stave model is applicable for explaining the
channel formation of Aib-containing peptides in this study. 
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The two steps would be required for the stability and assembly of channel forming
helical peptides, .g.peptaibols and transmembrane domains of channel proteins, in lipid
membranes [31-33]. In the first step, peptides interact with membranes through
hydrophobic and/or electrostatic interactions and then become thermodynamically
stabilized through strengthening of their intra-molecular hydrogen bonds.  In the second
step, after reaching equilibrium in lipid environment, the helical peptides further interact to
form peptide self-association (assembly) on lipid membrane surfaces or in their
hydrophobic interior leading to ion channel formation. 
CD results show that the conformations (helical contents) of the peptides change
drastically upon membrane binding.  [W12]BKBA-20 had a high affinity with membranes
and exhibited self-associated helical conformations in neutral and acidic membranes (Fig.
2-2 and 2-3).  The hydrophobicity of peptide is an important factor to the first step of
peptide-lipid interaction.  According to hydrophobicity scale for each amino acid residue
[41], the hydrophobicity of [W12]BKBA-20 is slightly higher than that of [W12]AKAA-20
(hydrophobicity scale for Aib was assumed to be an average of the Ala and Val
hydrophobicities [42]).  To examine the effect of the hydrophobicity on the peptide-lipid
interaction, Leu-peptide, Ac-(Ala-Lys-Ala-Leu)5-NH2 having a comparable hydrophobicity
to [W12]BKBA-20 was synthesized.  This peptide xhibited helical structure in DPPC
SUVs and had a high affinity toward DPPC, however, the Leu-peptide did not form ion
channel like that of BKBA-20 (data not shown), suggesting that not hydrophobicity but
Aib residues are important for ion channel formation (self-associated helical conformation).
The CD characteristics of [W12]BKBA-20 were comparable to those of alamethicin and
BKBA-20 in membranes.   Moreover, studies of the fluorescence emission indicated that
this peptide was buried deeper than that of [W12]AKAA-20 in the hydrophobic region of
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lipid membranes (Table 2-3).  These properties that high affinity, spontaneous binding,
self-association and deeper orientation of Aib-peptide would act as seeds for the ion
channel formation.  In contrast, [W12]AKAA-20 also formed helical conformations in
lipid membranes, however, did not exhibited the properties of [W12]BKBA-20.  Molle et
al. have reported structure-activity relationships of alamethicin analog (Alm-L2) that
replacement of all Aib residues by Leu residues [5, 6].  Alm-L2 forms multi-conductance
channels in the same manner as alamethicin, but its rate of switching between adjacent
conductance levels is considerably faster than original alamethicin (ca. 10 times).  Using
molecular modeling of alamethicin dimer and Alm-L2 dimer, Sansom et al. have reported
that this substitution has little effect on helix-helix packing [34].  Moreover, changing
three Leu residues per helix to Aib residues in a e novo designed channel-forming peptide
[from (LSLLLSL)3 to (LSLBLSL)3] resulted in alterations to both the channel conductance
and the channel lifetime [44].  These results suggested that introduction of Aib residue
into peptide backbone not only promotes the generation of stable helical conformations,
but also modulates the helix-helix packing.  Thus, it was presumed that Ala- or Leu-
containing peptide was not exhibited visible ion channels in lipid membranes. 
Interaction of Peptide with Negatively Charged Membranes¾ Tryptophan fluorescence
studies show that electrostatic interaction play also an important role in the interactions of
[W12]BKBA-20 or [W12]AKAA-20 with negatively charged lipid bilayers (Fig. 2-4 and 2-
5), as has been shown for many positively charged peptides [32, 33 and 39].  The
apparent partition coefficient Kp i  DPPC/DPPG (3:1) for [W
12]BKBA-20 is also larger,
but it is still of the same order of magnitude as for DPPC membranes.  In contrast, the Kp
value of [W12]AKAA-20 in DPPC/DPPG is smaller when compared with that of DPPC
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(Table 2-1).  This can be explained qualitatively by a preferential electrostatic interaction
between positively charged amino acid (Lys) residue of the peptide and negative charged
phosphate group of DPPG.  Such an interaction would lead to an increased concentration
of the corresponding peptide near the membrane surface.  For a qualitative discussion of
this electrostatic effect, we assume that the intrinsic coefficient K for the peptide
partitioning to DPPC and DPPC/DPPG membranes is identical.  Using Gouy-Chapman
theory [37], the next relationship between the apparent and intrinsic coefficients of the
peptide holds:
Kp = K exp(–zeffe0y 0/kT)
where zeff, e0, y 0 and k are the effective positive charge, the elementary electrical charge,
the surface potential (induced by negatively charged lipids) and the Boltzmann constant.
The measured Kp depends on zeff of peptide.  So, the change of zeff would be affected by
orientation of peptide in lipid membranes.  It is assumed that [W12]BKBA-20 forms the
barrel-stave structures (described above) in DPPC and DPPC/DPPG membranes because
of [W12]BKBA-20 showed comparable helical structures (Fig. 2-2) and orientation (Fig. 2-
4) in these two lipid systems.  According to barrel-stave structures, it seems reasonable to
assume that Lys side-chains of peptide is directed to central aqueous pore. Consequently,
the zeff values of [W
12]BKBA-20 is independent on the charge of membrane surface,
therefore, Kp is the same order of magnitude as for DPPC membranes.  In contrast, results
of fluorescence studies, [W12]AKAA-20 would lie on the membrane surface (Fig. 2-4 and
2-5). It is suggested that some [W12]AKAA-20 molecules are occupied the membrane
surface and zeff of [W
12]AKAA-20 that interacted with negatively charged lipid is more
higher compared with that of [W12]BKBA-20, therefore, [W12]AKAA-20 had a lower
affinity toward DPPC/DPPG. Moreover, [W12]AKAA-20 that occupied the membrane
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surface are presumed to be prevented the binding of other peptide to lipid membranes, as a
results, the Kp value in DPPC/DPPG is smaller when compared with that of DPPC. 
The Free Energy of Transfer of Peptide from Water to Membranes¾ [W12]BKBA-20 and
[W12]AKAA-20 partitioned into membranes with the apparent free energies D G values of
- 7.0 and - 7.7 kcal/mol, respectively (Table 2-1).  What are these values meant?  In size-
exclusion chromatography, [W12]BKBA-20 and [W12]AKAA-20 were mainly formed
dimer and monomer, respectively, when concentrations of peptides were 10 m M (data not
shown).  In addition to the structures of peptide in lipid membranes (discussed above),
D G of [W12]BKBA-20 is the sum of energies of folding in buffer, binding to membrane
surface, insertion into membrane and self-association.  For [W12]AKAA-20, D G is the
sum of energies of binding to membrane surface and folding on the membrane surface.
This suggestion indicated that Aib-peptide prefer to form self-association structures
(channel formation), whereas D G of Ala-peptide is consumed for binding to lipid
membranes. 
In conclusion, it has been suggested that a majority of known peptide or protein
ion channels form an associated conducting conformation i  phospholipid membranes.
From the present study, Aib-containing peptide takes a stable helical structure and strongly
interacts with phospholipid membranes leading to a self-associated conformation
compared to the corresponding Ala-containing peptide.  Aib-containing peptides with an
appropriate sequence can penetrate the membrane and produce stable ion channel-forming
structures. 
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2-5. Experimental Procedures
Materials—Fmoc-Aib-OH, Fmoc-Lys(Boc)-OH, Fmoc-Ala-OH, Rink Amide resins,
HBTU and NATA were purchased from Calbiochem-Novabiochem (Tokyo, Japan).
Fmoc-Trp-OH, DCC, HOBt and TFA were obtained from Peptide Institute (Osaka, Japan).
DPPC and DPPG were from Sigma (Missouri, USA).  Potassium iodide was obtained
from Nacalai Tesque (Kyoto, Japan). Acrylamide was from Bio-Rad Laboratories
(Richmond, CA).  All other chemicals from Wako Pure Chemical Industries Ltd. (Osaka,
Japan) were of special grade, and used without further purefication. 
Peptide Synthesis—The peptide synthesis was carried out through a stepwise solid-phase
peptide synthesis utilizing Fmoc-chemistry on as Rink Amide resins (90 mg, loading: 0.56
mmol/g, 100-200 mesh) [16].  Fmoc amino acid was pre-activated with HBTU-HOBt in
the presence of DIEA.  Coupling reaction was carried out for 50 min at room temperature.
Fmoc group was removed by 20% piperidine in DMF for 10 min.  After acetylation by
DCC/HOBt-AcOH, the resin was treated with TFA and suitable scavenger for 90 min at
room temperature.  The precipitated peptide by addition of ether was purified by gel-
filtration chromatography on a Bio-Gel P-2 (155350 mm) in 10 % acetic acid and then by
preparative HPLC on a Wakosil 5C4-200 column (105250 mm) using following solvent
system: (A) 95 % H2O/5 % CH3CN/0.05 % TFA; (B) 5 % H2O/95 % CH3CN/0.04 % TFA.
The homogeneity of the peptide was confirmed by analytical HPLC on a Wakosil 5C4-200
column (2.05150 mm) using the same solvent systems as described above.  The
structures of peptides were verified by amino acid analysis using the phenylisothiocyanate
method (Pico Tag Workstation, Waters, Milford, MA) and MALDI-TOF MS (Voyager-
DERP Biospectrometry Workstation mass spectrometer, PerSeptive Biosystems Inc.,
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Framingham, MA) with a -cyano-4-hydroxycinnamic acid (Aldrich Chem. Co, Milwaukee,
WI) as the matrix.  Aib and Trp residues were not detected by amino acid analysis using
the phenylisothiocyanate method (see also Section 3-5). 
[W12]BKBA-20.  Amino acid ratios in acid hydrolysate: Ala 3.9, Lys 5.0. MS Found:
m/z 2021.3, Calcd for (M+H)+ 2021.3. 
[W12]AKAA-20.  Amino acid ratios in acid hydrolysate: Ala 14.0, Lys 5.0.  MS Found:
m/z 1881.1, Calcd for (M+H)+ 1881.1.
Preparation of Liposomes—Small unilamellar vesicles (SUVs) were prepared by probe
sonication of DPPC and DPPC/DPPG (3:1) dispersion.  Lipids were solved in chloroform
and then dried in vacuo overnight.  These lipid films were hydrated with 50 mM
phosphate buffer solution (pH 7.4) solution and voltexed at 50˚C for 30 min and then
sonicated for 20 min using BRANSON SONIFIER 250(Branson, Danbury, CT). 
CD Spectra Measurement—CD spectra were measured on a Jasco J-720 spectro-
polarimeter (Tokyo, Japan) using a cylindrical cuvette of 1 mm path length.  The
instrument was calibrated with recrystallized camphorsulfonic acid-d10(Katay ma chemical,
Osaka).  The CD cuvette was washed with a concentrated NaOH aqueous olution
between determinations to remove any peptide adhering to its inner surface.  The peptide
concentrations of stock solutions were determined on the basis of the quantitative amino
acid analysis data.  All staffs for preparing and transferring the solution were siliconized
to prevent nonspecific adsorption of the hydrophobic peptides.  All Spectra were the
average of 10 scans obtained by collecting data at 0.2 nm intervals from 260 to 190 nm at
20 ˚C and the averaged blank spectra were subtracted.  The secondary structure contents
of peptides were calculated according to the Sreerama and Woody method [24].
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Peptide Binding to Phospholipid Membrane—The binding of peptide to phospholipid
membranes was measured using CD spectra of the peptide in the presence of varying
concentrations of lipid membranes.  Th  molar partition coefficients (Kp) were estimated
from CD data by a procedure detailed by White et al. [35]. The values of [q] n-p * as a
function of lipid concentration, L, are related to Kp by relation:
[q] n-p * = [KpL/(W + KpL)] [q] max + [1 - KpL/(W + KpL)] [q] free (1)
where [q] max and [q] free refer to the [q] n-p * values of bound and free peptides, respectively.
W is the molar concentration of water (55.56 M).  The value of [q] free was taken as the
measured value of peptide in buffer, and Kp and [q] max were used as parameters for fitting
to the experimental data. 
Fluorescence Measurement—Steady-state fluorescence emission spectra were measured
on a Jasco FP-750 spectrofluorometer (Tokyo, Japan) at 20 ˚C.  Excitation and emission
slit widths were 5 nm. An excitation wavelength of 280 nm was used for emission
spectra that were recorded from 300 to 450 nm. 
Fluorescence quenching experiments were performed using 295 nm excitation
wavelength in order to minimize absorptive screening by the quencher, potassium iodide or
acrylamide solutions.  Emission spectra were recorded from 310 to 450 nm.  Stock
solution of potassium iodide contained 1 mM sodium thiosulfate in order to prevent I3
-
formation.  The salt concentration was maintained at 200 mM with KCl solution.  For
potassium iodide quenching experiment, the fluorescence quenching data were analyzed
according to the Stern-Volmer equation:
F0/F = 1 + KSV[Q] (2)
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where F0 and F are fluorescence intensities in the absence and presence of quencher,
respectively, KSV is Stern-Volmer constant and [Q] is concentration of quencher.  For
acrylamide quenching experiment, the quenching data were analyzed according to the
modified Stern-Volmer equation [29]:
F0/(F0 - F) = 1/f + 1/(f KSV[Q]) (3)
where f is the fractional number of accessible fluorophores. 
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CHAPTER 3
The Position of Aib Residues Defines the Antimicrobial Activity
of Aib-Containing Peptides
3-1. Summary
2-Aminoisobutyric acid (Aib) is an unusual amino acid, which is present in some
antimicrobial peptides.  To elucidate the impact of Aib residues on the conformation and
biological activity of ion channel forming peptides, Aib residues in Ac-(Aib-Lys-Aib-
Ala)5-NH2 were partially and fully replaced by Ala residues.  A total of three analogs
were thus synthesized.  Two of these analogs, Ac-(Aib-Lys-Ala-Ala)5-NH2
 
(BKAA-20)
and Ac-(Ala-Lys-Aib-Ala)5-NH2
 
(AKBA-20), had the same amino acid composition and
intrinsic hydrophobicity, were not hemolytic, and exhibited clear differences in their
antimicrobial activities against Gram-positive bacteria.  The th rd analog, Ac-(Ala-Lys-
Ala-Ala)5-NH2, was biologically inactive.  Circular dichroism spectroscopy revealed that
the helix forming propensities of BKAA-20 and AKBA-20 were independent of the
position of Aib residues in negatively charged phospholipid vesicles, as mimics of external
cell membranes of bacteria.  However, the position of Aib residues in BKAA-20 and
AKBA-20 affected their antimicrobial activity.  It is indicated that introduction of Aib
residues into peptide backbone not only promotes the generation of stable helical
conformations, but also modulates the antimicrobial activity.  Results of this study can
implicate a deeper understanding of the role of Aib residues in structure-activity
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relationships of helical pore forming peptides, which in turn promotes the rational design
of effective antimicrobial peptides. 
3-2. Introduction
In the recent years, infection caused by microbes resistant to clinically used
antibiotics has resulted in a serious threat to public health globally [2-4].  The structure-
activity relationships of antimicrobial peptides have been widely investigated as part of the
search for novel broad-spectrum antibiotics [5-8].  It is known that many of these peptides
selectively interact with the negatively charged bacterial membranes and exhibit
antimicrobial activity by permeabilizing the membrane via ion channel formation and/or
disruption of its structure [9].  Naturally occurring antimicrobial peptides hare some
common features, despite the great diversity in their structures.  The common cationic
character of a majority of antimicrobial peptides is mostly due to the presence of lysine
and/or arginine residues.  Moreover, presence of amphiphathic secondary structures, with
polar side chains aligned along one side and hydrophobic residues along the opposite side,
are also proved to be crucial for the interaction of these peptides with bacterial membranes
[10-12].
Peptaibols (peptide with Aib and C-terminal amino alcohol), such as alamethicin,
were isolated from the fungi, and contain a high proportion of the unusual amino acid, 2-
aminoisobutyric acid (Aib [1]).  Peptaibols normally form a - and/or 310-helical
conformations in lipid membranes, generate transmembrane ion channels, and exhibit
strong antimicrobial and hemolytic activities.  We have previously reported the synthesis
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of an Aib-containing peptide, Ac-(Aib-Lys-Aib-Ala)5-NH2 (BKBA-20), which adopted a
highly amphiphathic helical structure in trifluoroethanol, phosphate buffer and
dipalmitoylphosphatidylcholine (DPPC) vesicles, exhibited well-defined ion channels in
diphytanoylphosphatidylcholine (DPhPC) bilayers, and had potent activities against Gram-
positive bacteria [13].  The impact of Aib residues and their position in the peptide
backbone on the antimicrobial activity and ion channel formation ability of Aib-containing
peptides can be of prime importance in understanding the structure-function relationships
of the naturally occurring peptaibols and their synthetic analogs.  So far, only a few
reports have been dedicated to this subject [14, 15].  In this study, to explore the role of
Aib residues in the antimicrobial ctivity and ion channel formation of Aib-containing
peptides, BKBA-20 was chosen as the template and Ala-substituted BKBA-20 analogs,
Ac-(Aib-Lys-Ala-Ala)5-NH2
 
(BKAA-20), Ac-(Ala-Lys-Aib-Ala)5-NH2
 
(AKBA-20) and
Ac-(Ala-Lys-Ala-Ala)5-NH2
 
(AKAA-20) were synthesized, and their conformation and
biological activities were evaluated and compared to the original peptide.  In these
peptides, the total number of the Lys residues, and therefore the overall positive charge of
the peptides, are preserved.  BKAA-20 and AKBA-20 share a similar number of Aib
residues, while AKAA-20 lacks Aib residues.  Consequently, it was found that all of the
synthesized peptides interact with biological membranes and their helix-forming
propensities are comparable in negatively charged lipid vesicles.  However, the total
number and positions of Aib residues in peptide sequences affected their interaction with
membranes and antimicrobial activity. 
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3-3. Results and Discussion
Peptide Synthesis—Until lately, Aib-containing peptides had only been synthesized by
stepwise solution techniques, since the solid-phase methods were mostly unsuccessful or
with very low yields. Recently, using Fmoc amino acid fluorides were proved to be
suitable, but not straightforward, for the solid-phase synthesis of Aib-containing peptides
[16, 17].  In a recent study, we have successfully synthesized an Aib-containing peptide,
BKBA-20, using conventional Fmoc-chemistry [13].  All four peptides of this study were
synthesized in a similar manner.  The Fmoc amino acid was pre-activated with HBTU-
HOBt in the presence of DIEA, and the stepwise synthesis proceeded with reasonable
yields. The crude peptides were obtained in high yields (81–96%).  The purification of
the synthetic peptides was carried out by preparative high-performance liquid
chromatography (HPLC). The homogeneity and structures of the purified peptides were
confirmed by analytical HPLC and MALDI-TOF mass spectrometry.
CD Spectroscopy—The secondary structures of peptides in various environments were
studied by CD spectroscopy.  The helical contents of peptides were calculated according
to the Sreerama and Woody method [18],　and are summarized in Table 3-1.  All four
peptides exhibited helical structures with low helical contents in 50 mM phosphate buffer
(pH 7.4).  Figure 3-1 shows CD spectra of peptides in the neutral phospholipid DPPC
(Fig. 3-1a), and the negatively charged phospholipid DPPC/DPPG (dipalmitoyl-
phosphatidylglycerol) (3:1) (Fig. 3-1b) small unilamellar vesicles (SUVs).  DPPC and
DPPC/DPPG liposomes were used as models for mammalian erythrocyte and bacterial
exterior cell membranes, respectively.  In the presence of DPPC/DPPG SUVs, all four
peptides exhibited comparable helical structures with typical double minimum bands at
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208 and 225 nm and a strong positive band at 194 nm.  Moreover, in 50% trifluoroethanol
/buffer, a membrane-mimicking environment [19, 20], CD spectra of all four peptides also
had comparable helical conformations (helical contents: 78-82%) (spectra not shown).
Therefore, it is plausible for these peptides to have similar helix forming propensities in
membrane-like environments, independent of the number and the position of Aib residues.
However, the helical contents of peptides in DPPC SUVs differed from those in
DPPC/DPPG SUVs.  The spectrum of AKAA-20 in DPPC is quite similar to the
spectrum of the peptide in buffer, suggesting that AKAA-20 may interact weakly with
DPPC.  The helical content of BKBA-20 in DPPC showed a similar value in
DPPC/DPPG SUVs.  Interestingly, AKBA-20 had a lower helical content than BKAA-20,
indicating that conformations of the two peptides in DPPC SUVs were different in spite of
the similarity in their amino acid composition and intrinsic hydrophobicity (the total
hydrophobicity of amino acid components of the peptide).  In general, it seems that both
amphipathicity and hydrophobicity are both important factors in the interaction of peptides
with neutral lipid membranes [21, 22].  Retention times on reversed-phase HPLC can be
interpreted as measures of peptide hydrophobicity and/or amphipathicity [23].  In the case
of amphipathic helical peptides, Houghten et al. have also reported that the induced
secondary structures of peptides, when bound to the hydrophobic C18 (octadecyl groups)
stationary phase, could influence the retention times [24, 25]. The retention times of
BKBA-20, BKAA-20, AKBA-20, and AKAA-20 were 18.27, 17.42, 16.42, and 15.73 min,
respectively.  These results were well correlated with the helical contents in DPPC SUVs.
It should be noted that the difference in the retention times of BKAA-20 and AKBA-20 is
due to their difference in amphipathicity, as their intrinsic hydrophobicity is similar.  
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Fig. 3-1.  CD spectra of Aib-containing peptides in (a) DPPC SUVs and (b)
DPPC/DPPG (3/1) SUVs.  Concentrations of peptide and lipid were 10 M and 2 mM,
respectively.  Spectra were measured at 30 ˚C. 
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Table 3-1.  Helicities of Aib-Peptides in Neutral and Acidic Vesicles
Helical contents (%) a)
Peptides phosphate buffer DPPC SUVs DPPC/DPPG b) SUVs
BKBA-20 39 80 80
BKAA-20 36 78 85
AKBA-20 43 59 88
AKAA-20 30 39 86
a) Helical contents were calculated according to the Sreerama and Woody method [18].
b) Molar ratio of DPPC:DPPG was 3:1.  Concentrations of peptide and lipid were 10
M and 2 mM, respectively. 
Hemolytic and Antimicrobial Activities—Biological activities of all four peptides were
evaluated as hemolytic and antimicrobial ctivities.  Figure 3-2 shows the hemolytic
activity of peptides against human erythrocytes.  Alamethicin, as a helical and highly
hemolytic peptaibol, was used as reference.  The half effective concentration of
alamethicin was about 20 m M.  The four peptides of this study exhibited very weak
hemolytic activities.  It has been reported that the peptides with higher hydrophobicity
exhibited stronger hemolytic activities due to the hydrophobic interaction of peptide with
the erythrocyte membranes that are mainly composed of neutral phospholipids [21, 24].
In our HPLC analysis, the retention time of alamethicin was 26.36 min (more hydrophobic
than the rest of the peptides of this study).  Consequently, results of hemolysis can be
partly attributed to the hydrophobic character of the peptides.  It seems that peptides with
comparable structures and hydrophobicities lower than a certain threshold  ( s judged by
the lower retention times compared to that of alamethicin) lose their hemolytic activities. 
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Fig. 3-2. Hemolytic activity of Aib-containing peptides for human erythrocyte (2%) in
10 mM phosphate buffer, 150 mM NaCl (pH 7.4).  Peptides: BKBA-20 (open circle),
BKAA-20 (open triangle), AKBA-20 (open square), AKAA-20 (closed circle), and
alamethicin (closed triangle).  The mixture of peptide and erythrocyte was incubated at
37 ˚C for 1 h.  All data are mean values of three experiments. 
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Table 3-2.  Antimicrobial Activity of Aib-Containing Peptides
MICs (m g/ml) a)
Peptides S. aureus B. subtilis E. coli
Alamethicin 12.5 6.25 >100
Gramicidin S 6.25 3.13 >100
BKBA-20 6.25 0.78 >100
BKAA-20 6.25 3.13 >100
AKBA-20 >100 >100 >100
AKAA-20 >100 >100 >100
a) The MICs (minimum inhibitory concentrations) were determined by the dilution method
in Bouillon agar medium.  Plates were incubated at 30 ˚C at 14 h. 
Table 3-2 shows the minimum inhibitory concentrations of the studied peptides
against bacteria Staphylococcus aureus, Bacillus subtilis, and Escherichia coli.  None of
the peptides were active against he Gram-negative bacteria, E. coli.  Antimicrobial
positively charged helical peptides such as magainins, which are active against E. coli, can
interact with the surface of the bacterial outer membranes and permeabilize the inner
membranes [26, 27].  There is a possibility that due to their conformation and
amphipathic pattern in aqueous environment and/or lipid bilayer surfaces, despite the
overall positive charge of the peptides (+5), none of the four peptides can effectively bind
to (and therefore penetrate through) the surface of bacterial outer membranes to approach
the inner membranes of E. coli. Conversely, another possibility can be due to the strong
interaction of the positive charges (Lys side-chains) with the negative charges on the
bacterial membrane surface, which hinders the further penetration of peptides into inner
bacterial membranes.  CD spectra of peptides in negatively charged vesicles support the
second assumption (strong interaction with induction of highly helical structures in
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membranes, Fig. 3-1b). However, the first assumption, or a combination of both
assumptions, cannot be completely ruled out due to the complexities of bacterial
membrane structures in comparison to simplified membrane models. The case is different
for the Gram-positive bacteria.  AKAA-20, which do not contain Aib residues, and
AKBA-20 were not active against the examined strains of Gram-positive bacteria despite
their amphiphathic cationic nature. In contrast, BKBA-20 showed potent activities against
Gram-positive bacteria [13]. BKAA-20, having the same amino acid composition to
AKBA-20, exhibited comparable activities to BKBA-20 and gramicidin S (a broad-
spectrum potent cyclic antimicrobial peptide), and stronger activities than alamethicin,
against Gram-positive bacteria.  These results indicated that the position of Aib residues
in the peptide backbone affected their antimicrobial activity, which can be explained by
relating the amphipathicity and hydrophobicity to antimicrobial activity [24, 28, 29].  To
evaluate the enzymatic stabilities of BKAA-20 and AKBA-20, tryptic digestion assay was
carried out.  AKBA-20 had a higher resistance to digestion than BKAA-20.  This
suggests that the difference in the antimicrobial ctivities of BKAA-20 and AKBA-20
cannot be explained by the proteolytic effect of bacterial proteases on peptides. 
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Ion Channel Formation—Ion channel formation is one of the proposed mechanisms for
antimicrobial activity of peptides.  Figure 3-3 shows the conductance patterns of all four
peptides, measured by the tip-dip patch-clamp technique. DP PC lipid was selected for
these experiments because of its ability to form mechanically stable membranes.  BKBA-
20 formed well-defined single-state channels at 100 mV membrane potentials [13] (Fig. 3-
3a).  BKAA-20 also formed ion channels, and its molecular assembly for channel
formation was more homogeneous rather than BKBA-20 (Fig. 3-3b).  AKBA-20
exhibited channel-like activities, however, its conductance patterns were irregular stray
fluctuations with an erratic increases in the membrane current (Fig. 3-3c).  The
conductance of BKAA-20 and AKBA-20 were 100 and 90 pS, respectively.  Howe r,
the relative probability for detecting the conducting states was higher in BKAA-20
compared to AKBA-20.  As shown in Fig. 3-3d, the non Aib-peptide, AKAA-20, did not
form visible ion channels.  Consequently, there was a clear correlation between the
antimicrobial and the ion channel activities.  The peptides that formed ion channels with
defined conductance patterns, BKBA-20 and BKAA-20 were also more active against
Gram-positive bacteria.  Therefore, it is plausible that the ability to form ion channels is
part of the mechanism of antimicrobial activity of these peptides.
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Fig. 3-3. Conductance patterns of (a) BKBA-20, (b) BKAA-20, (c) AKBA-20, and (d)
AKAA-20 in DPhPC bilayer at 25  2 ˚C.  The electrolyte solution was 500 mM KCl
buffered with 5 mM HEPES (pH 7.4).  The electrolyte composition was symmetrical on
both sides of the membrane, and peptide concentration was 100 nM.  The applied
membrane potential was 100 mV.  The states of open and closed, determined from the
current amplitude histogram, are represented as O and C, respectively. 
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3-4. Conclusion
In the present study, the role of Aib in the biological activity of a series of model
helical peptides was explored in some detail.  Aib is commonly found in the naturally
occurring antimicrobial peptaibols.  Structure-function relationship studies in BKBA-20
(a helical and antimicrobial synthetic peptide) and its analogs suggested that alternately
arranged Aib residues are significant for not only inducing stable helical conformations,
but also the biological activity of these peptides.  It was found that the helix forming
propensities of the synthesized peptides were independent of the position of Aib residues
in the negatively charged DPPC/DPPG vesicles, although the helical contents of peptides
were sequence dependent and affected in DPPC vesicles.  Peptide structures in
membranes and their ion channel forming ability in lipid bilayers had a clear correlation
with their antimicrobial activity against Gram-positive bacteria, but not with their
hemolytic activity.  Moreover, the positions of Aib residues in the peptide sequence
affected the biological activity.  An analog of BKBA-20, BKAA-20, had considerable
antimicrobial activity, but was not hemolytic (a desirable therapeutic property).  Another
analog, AKBA-20, which was different from BKAA-20 only in the relative positions of
Aib residues, was neither antimicrobial nor hemolytic. It is therefore shown that despite
structural similarities in lipid membranes and comparable intrinsic hydrophobicity, the
position of Aib residues and overall change in the amphipathicity of peptide molecules can
significantly alter their biological activity. This is an interesting and important finding that
can be utilized in the design of novel helical antimicrobial peptides possessing high
therapeutic potencies without cytotoxicity.  Presently, based on the results of this work
and to optimize the therapeutic properties of Aib-containing helical templates, synthesis
and structure-function studies of these peptides are being undertaken in our laboratories. 
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3-5. Experimental Procedures
General—Fmoc-Aib-OH, Fmoc-Lys(Boc)-OH, Fmoc-Ala-OH, Rink Amide r sins (0.56
mmol/g, 100-200 mesh), and HBTU were purchased from Calbiochem-Novabiochem
(Tokyo, Japan).  DCC, HOBt, and TFA were obtained from Peptide Institute (Osaka,
Japan). The standard amino acid mixture (type H) and phenyl isothiocyanate were
obtained from Wako Pure Chemical Industries Ltd. (Osaka, Japan).  DPPC d DPPG
were from Sigma (Missouri, USA).  DPhPC was obtained from Avanti Polar Lipids
(Alabaster, AL) as 50 mg/ml chloroform solutions.  All other chemicals from Wako Pure
Chemical Industries Ltd. were of special grade, and used without further purification. 
RP-HPLC was conducted on a JASCO chromatography recorder (Tokyo, Japan)
with a UV-970 Intelligent UV/Vis detector at 220 nm and 807 IT Intelligent Integrator.
Eluents were solution A (95% H2O/5% CH3CN/0.05% TFA) and solution B (5% H2O/95%
CH3CN/0.04% TFA).  Mass spectra were measured on a MALDI-TOF MS (Voyager-
DERP, PerSeptive Biosystems Inc., Framingham, MA) with a -cyano-4-hydroxycinnamic
acid (Aldrich Chem. Co, Milwaukee, WI) as the matrix.  Amino acid analysis was
performed on a Pico Tag Workstation (Waters, Milford, MA) after hydrolysis in a
constant-boiling hydrochloric acid at 110 ˚C for 24 h. 
Peptide Synthesis—The peptide synthesis was carried out through a stepwise solid-phase
peptide synthesis utilizing Fmoc-chemistry on as Rink Amide resins [13]. Ten-fold
molar excess of the Fmoc amino acid was pre-activated with HBTU-HOBt in the presence
of DIEA for 20 min.  Coupling reaction was carried out for 50 min.  Fmoc group was
removed by 20% piperidine in DMF for 10 min.  After acetylation by DCC/HOBt-AcOH,
the resin was treated with TFA/H2O (90/10, v/v) for 90 min at room temperature.  The
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precipitated peptide by addition of ether was purified by preparative HPLC on a Wakosil
5C4-200 column (105250 mm).  Gradient; 20-100% B in 60 min with a linear gradient
at a flow rate of 2.0 ml min–1.  The homogeneity of the peptide was confirmed by
analytical HPLC on a Wakosil 3C18 RS column (2.05150 mm).  Gradient; 0-100% B in
30 min with a linear gradient at a flow rate of 0.25 ml min–1.  Structures of peptides were
verified by amino acid analysis and MALDI-TOF MS.  De Filippis et al. reported that the
reaction of phenyl isothiocyanate with Aib led to the formation of phenylthiocarbamyl
(PTC)-Aib and cyclic phenylthiohydantoin (PTH)-Aib derivatives [30]. In our amino
acid analysis two peaks were observed, which corresponded to these derivatives.
However, these peaks were not reproducible, and as a result Aib residues were not
estimated under our analysis conditions.  Concentrations of peptide solutions were
determined by estimations based on PTC-Ala and PTC-Lys derivatives.  Synthesis of
BKBA-20 has been recently reported in detail [13].  
BKAA-20.  Yield of crude peptide: 90%.  Amino acid ratios in acid hydrolysate: Ala
9.7, Lys 5.0.  MS Found: m/z 1837.9.  Calcd for (M+H)+ 1837.3. 
AKBA-20.  Yield of crude peptide: 81%.  Amino acid ratios in acid hydrolysate: Ala
10.1, Lys 5.0.  MS Found: m/z 1837.2.  Calcd for (M+H)+ 1837.3. 
AKAA-20.  Yield of crude peptide: 96%.  Amino acid ratios in acid hydrolysate: Ala
14.7, Lys 5.0.  MS Found: m/z 1766.8.  Calcd for (M+H)+ 1767.1. 
Preparation of Liposomes—Small unilamellar vesicles were prepared by probe sonication
of DPPC or DPPC/DPPG (3:1 molar ratio) dispersions.  Lipids were solved in chloroform
and then dried in vacuum overnight.  These lipid films were hydrated with 50 mM
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phosphate buffer solution (pH 7.4) and voltexed at 50 ˚C for 30 min and then sonicated for
20 min using Branson Sonifier 250 (Branson, Danbury, CT). 
CD Spectra Measurement—CD spectra were measured on a Jasco J-720 spectro-
polarimeter (Tokyo, Japan) using a cylindrical cuvette of 1 mm path length.  The
instrument was calibrated with recrystallized camphorsulfonic acid-d10 (Katayama
chemical, Osaka).  The CD cuvette was washed with a concentrated NaOH aqueous
solution between determinations to remove any peptide adhering to its inner surface. The
peptide concentrations of stock solutions were determined on the basis of the quantitative
amino acid analysis.  All staffs for preparing and transferring the solution were
siliconized to prevent nonspecific adsorption of the hydrophobic peptides.  Samples were
incubated at room temperature for 30 min.  All Spectra were the average of 10 scans
obtained by collecting data at 0.2 nm intervals from 260 to 190 nm at 30 ˚C.  The helical
contents were calculated according to the Sreerama and Woody method [18].
Antimicrobial Assay―The minimum amounts of Aib-peptides necessary for complete
inhibition of the growth of Bacillus subtilis PCI 215, Staphylococcus aureus FDA 209P,
and Escherichia coli B were determined by the dilution method in Bouillon agar medium.
Plates were incubated at 30 ˚C for 14 h.  Alamethicin and gramicidin S were used as
reference compounds.  The minimum inhibitory concentration (MIC) of each peptide is
reported as the average of triplicate measurements.
Hemolytic Assay―The hemolytic activities of Aib-peptides were determined using human
erythrocytes.  The erythrocytes were collected from heparin-treated blood by
centrifugation (at 2500 rpm at 4 ˚C for 5 min) and washed four times with phosphate-
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buffered saline (PBS: 10 mM phosphate buffer, pH 7.4/150 mM NaCl) to remove plasma
and buffy coat.  Suspensions of 2% erythrocytes in PBS with or without peptides were
incubated at 37 ˚ C for 1 h.  Hemolysis was evaluated as the release of hemoglobin
(absorbance at 570 nm) of the supernatant after centrifugation at 2500 rpm at 4 ˚C for 5
min.  A 100% hemolysis was determined by the hemoglobin release after the addition of
0.3% Triton X-100. Alamethicin was used as reference compound.  The hemolytic
activity of each peptide is reported as the average of triplicate measurements.
Single-Channel Measurement—Patch-clamp experiments were performed using tip-dip
technique at room temperature (25 ± 2 ˚C), as was generally described [13, 31]. The
patch pipettes were of the hard-glass type, were prepared by the two-pull method by a
pipettes-puller (Narishige, Tokyo) to give an approximate diameter of 1 m m.  The
electrolyte solutions were comprised of 500 mM KCl solutions buffered with 5 mM
HEPES (pH 7.4).  The electrolyte composition was symmetrical for both sides of the lipid
bilayer. Peptide concentration was 100 nM, when added to patch pipettes.  The
chloroform solutions of DPhPC was mildly evaporated by N2 flushing, and the residual
lipids were redissolved in hexane (2 mg/ml) before being spread on an aqueous surface.
DPhPC hexanic solution was added to the aqueous surface of electrolyte solutions (about 2
m l) in plastic dishes with 3.5 cm diameters.  Single-channel current was measured using
an Axopatch 1D patch-clamp amplifier (Axon Instruments) controlled with pClamp 6
(Axon Instruments) software.  Data were filtered at 2 kHz frequency, stored directly on a
hard disk, and analyzed with an Axograph (Axon Instruments). 
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CHAPTER 4
Effect of , -Dialkyl Amino Acid Residues in Peptide
Antibiotics on the Enhancement of Protease Resistance
4-1. Summary
Naturally occurring peptide antibiotic exhibited low stability in vivo.  Enhancing
protease resistance of peptide is required for using peptide antibiotic as a drug.  a , a -
Dialkyl amino acid is an unusual amino acid and is presented in peptide isolated from
fungi and plants.  The details of enzymes that catalyzed a , a -dialkyl amino acid-
containing peptides remain unclear.  To investigate the effect of a , a -dialkyl amino acid
residue in peptide antibiotic on the protease resistance, tryptic and serum digestion assay of
Aib-containing peptide were carried out.  The introduction of Aib residues to P1’
positions were increased the digestic resistance.  Alternately arranged Aib residues in
peptides as peptaibols resulted a completely resistance. Th  result is to be expected for
the design and synthesis of rational peptide antibiotics having increased protease
resistances without decreasing the biological activity. 
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4-1. Introduction
Peptide antibiotic has a broad-spectrum against gram-positive, gram-negative
bacteria, fungi, protozoa and viruses, and is hard to make resistant bacteria.  The
structure-activity relationships of peptide antibiotics have been widely investigated as part
of the search for novel antibiotics having a potent antimicrobial activity and low
cytotoxicity [1-4].  However peptide antibiotics are low stability in vivo because of the
peptide bonds are easily digested by protease.  Several strategies have been employed to
enhance protease resistance.  N-t rminal acylation and C-terminal amidation are useful
for exopeptidase r sistance.  Chemical modifications of peptide bonds such as retro,
enantio and retro-enantio peptides howed similar activity to original peptide and had
resistances to the enzymes released from bacteria [5].  Another modifications of peptide
bond, amide [6], peptoid [7], carbamate [8], and azatide [9] have been also employed for
biological active peptides.  However, these modifications are difficult to perform and can
change the peptide conformations. 
Introduction into peptide of unusual amino acids, such as D-amino acid and
sterically constrained amino acid, in the peptide backbone are also expected to induce
protease resistance.  Studies of structure-activity relationships of antibiotic peptides has
shown that insertion of D-amino acids in both N- and C-terminals of peptide can increase
their resistance to enzymatic digestion, while preserving their original antimicrobial
activity [10].  However, D-amino acid replacement at a specific position (the middle of
the peptide) may decrease the activity because it may change the secondary structure of the
peptide, which is considered to be one of the important factors in antimicrobial activity
[10,11].  a , a -Dialkyl amino acid is an unusual amino acid and is presented in peptide
antibiotic.  These amino acid-containing peptides form and stabilize peptide structures
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[12-16], suggesting that this property is convenience for protease resistance.  In addition,
the enzymes that recognized the a , a -dialkyl amino acid residue in peptide are not clear in
detail.  In this study, to elucidate the effect of a , a -dialkyl amino acid residue of peptide
antibiotic on the protease resistance, tryptic and serum digestion assay of Aib-containing
peptides were measured. 
4-3. Results and Discussion
a , a -Dialkyl amino acid-containing peptide antibiotic family, peptaibols, forms
self-assemble helical conformation in lipid membrane and exhibits the voltage-dependence
ion channel ike a channel protein [17, 18].  Recently, it is reported that peptaibols
represent a novel and powerful class of elicitors that can induce multiple metabolic
activities such as ethylene emission, biosynthesis of volatile substances, and tendril coiling
[19]. In spite of these interesting biological activities, biosynthesis and degradation of
these peptides in detail, interaction of peptaibols with enzymes, have not been understood. 
Peptide Design—2-Aminoisobutyric acid (Aib) and 1-aminocyclopropanecarboxylic acid
(Acc) are most simple a , a -dialkyl amino acids. These amino acids are present in
peptaibols [20] and a hormone involved in the ripening of fruit [21], respectively.  It is
known that the cyclopropyl group of Acc is a low chemical stability [22], while Aib is very
stable structure and Aib-containing peptide forms stable helix conformation [13,14].  In
addition, the effect of a , a -dialkyl amino acid residues on the properties of short peptide
sequences may not clear. Ac-(Aib-Lys-Aib-Ala)5-NH2
 
(BKBA-20), therefore, was
designed.  Ala-substituted BKBA-20 analogs, i.e. Ac-(Aib-Lys-Ala-Ala)5-NH2
 
(BKAA-
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20), Ac-(Ala-Lys-Aib-Ala)5-NH2 (AKBA-20) and Ac-(Ala-Lys-Ala-Ala)5-NH2 (AKAA-
20) were also designed to evaluate the effects of the position of Aib residue for protease
resistance.  The peptide synthesis has been reported in detail [30]. 
Tryptic Digestion—Endopeptidase resistances of Aib-peptides were measured. Elastas
and thermolysin belong to a class of serine protease family, a well-characterized
endopeptidase, and are specific protease for the hydrophobic amino acid residue.  Rival et
al. reported in their enzymatic peptide synthesis studies that a , a -dialkyl amino acids such
as Aib did not interact with these two proteases [23].  Apparently, these two proteases do
not recognize Aib residue, despite the fact that they have been used in peptide synthesis.
Instead we used trypsin, also one of the serine protease, as a specific endopeptidase for the
five Lys residues of BKBA-20.  Time-course analysis of tryptic digestion was measured
by RP-HPLC and MALDI-TOF MS. 
Figure 4-1 shows HPLC profiles of tryptic digestion of peptides that peptide and
enzyme were incubated for 90 min.  The non Aib-peptide, AKAA-20 (retention time: 8.07
min), was immediately digested by trypsin within 30 min in 100 mM Tris-HCl, 5 mM
CaCl2 (pH 8.0) at 30 ˚C (Fig. 4-1).  In the case, a new peak corresponding to H-Ala-Ala-
Ala-Lys-OH (retention time: 3.23 min) was observed.  An ion peak corresponding to Ac-
(Ala-Lys-Ala-Ala)4-Ala-Lys-OH was also observed by TOF MS measurements after
AKAA-20 and trypsin were incubated for 5 min, suggesting that trypsin digested AKAA-
20 from C-terminal lysine fragment.  In contrast, he Aib-peptide, BKBA-20, was not
digested by trypsin under the same conditions (Fig. 4-1). Moreover, BKBA-20 was not
also digested when peptide-trypsin mixture was incubated for 24 h or peptide-to-trypsin
ratio was 10:1.  These results were also conformed by TOF MS measurements. 
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To elucidate the effect of position of Aib residue in same detail, tryptic digestion
assay of BKAA-20 and AKBA-20 were carried out (HPLC profiles are shown in Fig. 4-1.).
Figure 4-2 shows the time-course of percentage of digested peptides that were estimated by
the peak-area of the parent peptides that obtained from RP-HPLC profiles.  The half-lives
of peptides (t1/2), except BKBA-20, were evaluated by the first-order reaction.  BKAA-20,
with Aib residues before Lys residues (P2 position) was immediately digested by trypsin in
a comparable manner as AKAA-20.  AKBA-20, in which Aib residues were positioned
after Lys residues (P1’ position), had a resistance for tryptic digestion compared to BKAA-
20 and AKAA-20.  The half-live of AKBA-20 (31.74 min) was about 19 times as long as
these of BKAA-20 and AKAA-20 (1.69 and 1.67 min respectively).  It can be suggested
that a steric hindrance of Aib residue in AKBA-20 affects its tryptic digestion.  However,
the resistance of AKBA-20 was not as much as BKBA-20.  AKBA-20 was digested
within 3 h.  These results indicated that BKBA-20, with alternately arranged Aib residues,
has a complete resistance for tryptic digestion. 
Table 4-1.  Values of half-live (t1/2) and inhibition constant (KI) toward trypsin of
peptide a)
peptide t1/2 (min) KI (m M) 
b)
BKBA-20 N.D. c) 437
BKAA-20 1.69 497
AKBA-20 31.74 464
AKAA-20 1.67 219
a) All measurements were carried out in 100 mM Tris HCl (pH 8.0), 5mM CaCl2.  b) The
KI were estimated by Dixon plots.  c) not determined. 
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Fig. 4-1. HPLC profiles of tryptic digestion of peptides in 100 mM Tris-HCl buffer
with 5 mM CaCl2 (pH 8.0) at 30 ˚C.  (a): without enzyme, (b): after incubated for 90 min.
Concentrations of peptide and trypsin were 200 and 1 M, respectively.  Conditions of
RP-HPLC analysis are described in Experimental Procedures. 
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Fig. 4-2.  The time-course of percentage of digested peptides.  Peptides: BKBA-20
(open circle), BKAA-20 (open triangle), AKBA-20 (closed circle) and AKAA-20 (closed
triangle).  The percentage of digested peptide was estimated by the peak-area of the
parent peptide that obtained from RP-HPLC profile. Experimental conditions were
similar to in Figure 1. The half-lives of peptides (except BKBA-20) were evaluated by the
first-order reaction (ln [non-digested peptide] = kt; where k is first-order constant).  All
data are mean values of duplicate experiments. 
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Fig. 4-3. Stability of peptide in human serum.  Aib-peptides (200 M) were incubated
in 15 % human serum for 1 h (white bars) or 2 h (solid bars) at 37 ˚C.  The percentage of
non-digested peptide was estimated by the peak-area of the parent peptide that obtained
from RP-HPLC profile.  All data are mean values of duplicate experiments. 
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Inhibitory Activity—The inhibitory activity of peptide toward trypsin was estimated from
the residual activity of trypsin against the hydrolysis of L-BAPA.  When concentrations of
L-BAPA and peptides were 200 and 250 m M, all four peptides were weakly decreased
activities of trypsin (residual activity about 80 %).  The inhibition constants (KI) of
peptides toward trypsin were estimated by Dixon plots, and summarized in Table 4-1.
Apparent KI of all four peptides were comparable and higher (10
–4 M) compared to that of
leupeptin (10–6 M), well-known inhibitor of trypsin-like serine and thiol proteases [24]. 
Results of these suggested that all peptides in this study are substrates rather than inhibitors.
Why dose BKBA-20 have a complete resistance for trypsin?   Restriction of peptide
conformation often shows an enhanced protease resistance.  To assess the a -helix
forming potential and the helical stability, CD spectra of peptides (200 m M) n buffer were
measured.  Previously, we have reported that all four peptides form helical conformations
with low helical contents in 50 mM phosphate buffer (pH 7.4) [25].  Similar spectra were
observed in 100 mM Tris-HCl, 5 mM CaCl2 (pH 8.0). However, helical stability of
peptides, estimated by urea denaturation, were in the following order: BKBA-20 >>
AKBA-20 > BKAA-20 > AKAA-20 (data not shown).  This order was correlated with
tryptic resistances of peptides.  Thus, the stability of conformation is one of the
reasonable factors for tryptic digestion. 
Serum Assay—Exopeptidase r sistances of Aib-peptides were also measured in human
serum.  Figure 4-3 shows stability of Aib-peptides (200 m M) in presence of 15 % human
serum.  Percentages of non-digested peptides were measured by RP-HPLC.  In the study
of D-amino acid containing antimicrobial peptides, exopeptidases in the serum played a
major role in the digestion of peptide [26].  Serum protease resistances of Aib-peptides
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differed although these three Aib-peptides were blocked by acetylation and amidation.
BKBA-20 quite resistant and was quite non-digested by serum protease, whereas 33 and
21 % of BKAA-20 and AKBA-20 were digested, respectively (within 1 h at 37 ˚ C).
However, the latter peptides showed the same amount of digestion (35 %) after longer
incubation (2 h at 37 ˚C).  These peptides have thus similar tendencies to tryptic digestion
(Fig. 4-2).  Consequently, these results indicated that BKBA-20, with alternately arranged
Aib residues, has almost completely resistance to proteases. 
4-4.  Conclusion
In the present study, to evaluate the effect of a , a -dialkyl amino acid residue in
peptide antibiotic for the protease digestion, serum and trypsin digestion of Aib-containing
peptides were measured.  Interestingly, BKBA-20 has a completely resistance to serum
protease and trypsin, supposing that alternately arranged Aib residues observed into
peptaibols are significant for the protease resistances to inhibit the growth of other
organisms.   Unusual amino acid such as a , a -dialkyl amino acid residue is introduced
into peptide backbones by non-ribosomal systems [27]. The presence of alamethicin
synthetase was reported in actually [28], however, detailed mechanism of the enzyme and
primary structure remains unclear.  So, BKBA-20 and related analogs are to be expected
for the good substrates of affinity-column for the enzymes that catalyzed Aib-peptide. 
AKBA-20 had a higher resistance for protease digestion than BKAA-20, though
AKBA-20 showed similar helix conformation to BKAA-20.  It is indicated that the
position of Aib residue in peptide was enhanced a resistance without the limitation of
introducing position as a D-amino acid. Natural peptide antibiotics have multi lysine
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and/or arginine residues in the whole of the peptides, which necessary characters for the
antimicrobial activity [3, 4 and 29].  The introduction into these suitable positions of Aib
residue is useful for increasing protease resistances without decreasing the activity (the
effective therapeutic antibiotics).  Therefor, these results also are to be expected for the
design of novel peptide antibiotics with protease resistance. 
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4-5. Experimental Procedures
Materials—All chemicals were of special grade, and used without further purification.
The peptide synthesis wa  carried out through a stepwise solid-phase peptide synthesis
utilizing Fmoc-chemistry [30]. 
Tryptic Digestion Assay—N-Tosyl-L-phenylalanyl chloromethyl ketone-treated trypsin
(Worthington, Lakewood, NJ) was used for digestion assay.  Tryptic digestion of the
peptides were carried out in 100 mM Tris-HCl, 5 mM CaCl2 (pH 8.0) for several times at
30 ˚C. Concentrations of peptide and trypsin were 200 and 1 m M, respectively.  Time
course analysis of tryptic digests was measured by reversed phase high-performance liquid
chromatography (RP-HPLC) and matrix-assisted laser desorption ionization time-of-flight
mass spectroscopy (MALDI-TOF MS).  RP-HPLC analysis was conducted on a JASCO
chromatography recorder with a UV-970 Intelligent UV/Vis detector at 220 nm and 807 IT
Intelligent Integrator (Tokyo, Japan) at 25 ˚C.  Eluents were solution A (95 % H2O/5 %
CH3CN/0.05 % TFA) and solution B (5 % H2O/95 % CH3CN/0.04 % TFA).  The column
was Wakosil 5C4 200 (4.65250 mm).  The linear gradient was 0-100 % B in 30 min at a
flow rate of 1.0 mL/min. Mass spectra were measured on a PerSeptive Biosystems
Voyager-DERP (Framingham, MA) with a -cyano-4-hydroxycinnamic acid as the matrix. 
Human Serum Protease Digestion Assay—The human serum was collected from heparin-
treated blood by centrifugation (at 3500 rpm at 4 ˚C for 20 min). A 25 % human
serum/RPMI-1640 medium (Sigma, Missouri, USA) was prepared and incubated at 37 ˚C
for 15 min.  The peptide was then added to the reaction mixture.  Final concentrations of
peptide and serum were 200 m M and 15 %, respectively.  The mixture was incubated at
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37 ˚C and at known time intervals 50 m L alquots were removed and quenched with 50 m L
of 10 % trichloroacetic acid solution.  The resulting samples were cooled at 4 ˚C for 15
min, then spun at 4 ˚C and 10000 rpm for 20 min.  The supernatant was removed and
analyzed by RP-HPLC. 
Inhibitory Activity—The inhibitory activity of peptide toward trypsin was estimated from
the residual activity of trypsin against the hydrolysis of benzoyl-L-arginine p-nitroanilide
(L-BAPA).  Concentrations of L-BAPA were 200 and 400 m M.  The final peptide
concentrations were in the range 125- 500 m M.  Peptide and trypsin were mixed and
incubated in 100 mM Tris-HCl, 5 mM CaCl2 (pH 8.0) at 25 ˚C for 10 min.  L-BAPA was
then added to the reaction mixture.  After 3 min incubation at 25 ˚C, the reaction was
terminated by 30 % acetic acid. The extent of hydrolysis was calculated by monitoring
the absorbance at 405 nm (e 405  = 9920).  The inhibition constants of peptides toward
trypsin were estimated by dixon plots. 
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CHAPTER 5
Overview and Conclusion
A few structure-activity relationships of Aib-containing peptides with long chain
length (~ 20 residues) have been investigated because of the synthetic difficulties.  In this
work, to explore the role of Aib residues in conformations and biological activities of
channel forming Aib-peptides with 20 residues and high proportion of Aib, BKBA-20 and
related analogs were designed and synthesized.  In this chapter, the role of Aib residue in
peptide backbone is discussed.
5-1. Conformational Propensity of Aib Residue
Aib residue is a natural, unusual (non-standard) amino acid that has been found in
antibiotic and channel-forming peptides (peptaibol) of microbial origin [Chapter 1].  A
variety of experimental studies conducted on “short peptides” have shown that Aib mainly
forms and stabilizes helical conformations [1, 2].  In particular, Aib prefers the formation
of 310-helices in homooligomers of Aib [3, 4].  However, Aib stabilizes the a -helical
structures when “a single Aib residue” is incorporated into a synthetic peptide [5].
Moreover, Aib residue has been reported to possess a slightly higher intrinsic helical
propensity than Ala residue, which is the most helix-favoring among the 20 standard
(protein) amino acids along with the Leu residue [6, 7].  In this respect, theoretical studies
have indicated that the helix-stabilizing effect of Aib residue is caused by the geminal
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methyl groups that severely reduce the allowed conformational space and restrict he
peptide backbone torsion angles (, ) to those characteristic of the helical configuration
[5, 8-10]. Therefore, the introduction of Aib into a polypeptide chain is expected to
indirectly stabilize the folded structure by decreasing the chain entropy of the unfolding
state.  This principle has been previously proposed and experimentally verified by
exchanging Gly with Ala in proteins [11-13].  Both Gly ®  Ala and Ala ®  Aib
replacements introduce at the Ca  atom an extra methyl group that greatly reduces the
possible conformations of the peptide chain in the unfolded state, thus shifting the
equilibrium to the folded state [11]. 
In the present work, the conformations of BKBA-20 and related the analogs with
high proportion of Aib and long chain-lengths were investigated.  In buffer and/or TFE
solutions, these peptides form comparable helical conformations as expected.  Thes  helix
conformations were not independent of number and position of Aib residues [Chapter 3].
In preliminary results, moreover, experiments of thermal and urea denaturation showed
that helical stability of Aib-peptides in buffer solution were higher compared with those of
non Aib-peptides.  These stability was increased with enhancing peptide-concentrations,
suggesting that long chain-length Aib-peptides prefer to form self-associated structures. 
5-2. Role of Aib Residues in Long-chain Peptides with High Aib Content
Aib-Containing Peptide Prefer to Form the Self-Associated Structure Leading to Ion
Channel Formation—The tip-dip patch-clamp technique revealed that Aib-containing
peptides (BKBA-20, BKAA-20 and AKBA-20) formed ion channels compared with Ala-
or Leu-peptides in DPhPC bilayers, though conductances and lifetimes of individual
83
channels were the intrinsic properties [Chapter 3].  Ion channel formations of “non Aib-
containing peptides” corresponding to putative transmembrane domains of channel
proteins or peptide antibiotics have been widely investigated.  Oiki et al. reported that an
amphipathic peptide, NaIS3, which corresponds to the S3 segment of the first repeat of the
rat brain I sodium channel, was able to form cation-selective channels [14].  However,
these channels had heterogeneous conductance and the major species had conductance of
15–25 pS that is comparable to the 20 pS conductance of the native channel.  In anot er
study, the channel-forming properties of peptides corresponding to all six putative
transmembrane domains (TM) of the first repeat CFTR phosphorylation-regulated chloride
channel have been investigated [15].  Both TM2 and TM6 amphipathic peptides exhibited
anion-selective channels with two primary conductances and sporadic events of both
higher and lower conductance.  However, the TM1, TM3, TM4 and TM5 hydrophobic
peptides were found not to elicit discrete gated channels, but displayed irregular current
fluctuations that indicated incorporation into the membrane.  Montal et al.reported that
the amphipathic M2d AchR peptide, corresponding to the M2 segment of the Torpedo
receptor d -subunit that is believed to be one of the five homologous pore-lining segments,
has been found to form cation-selective channels of heterogeneous conductance and
lifetime [16, 17].  These results of heterogeneous conductance suggest that
transmembrane domains having channel activities are hardly able to form stable self-
associated structures leading to channel formations of homogeneous conductance.
Actually, template-attached t tramer of M2 segment of the Torpedo receptor d -subunit
formed cation-selective channels of homogeneous conductance that is comparable to the
native channel [16].  Moreover, mixture of TM2 and TM6 of CFTR exhibited discrete
channels with properties different from those of the single peptides, presumably indicating
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the formation of heterooligomers.  These channels were of more uniform conductance
and had long lifetimes [15].  On the other hand, it is known that peptide antibiotics such
as magainins, cecropins and mellitin, also exhibit channel-like activities [18].  However,
more typical patterns for these peptides-induced electrophysicological events are erratic
current or occasional multilevel fluctuations, which have a pronounced lytic activity on
membranes at higher peptide concentrations, suggesting that these peptides caused
presumably formation of holes or membrane perturbation rather than formation of
channels. 
Our CD studies of BKBA-20 and related analogs showed the peptides form self-
associated structures in lipid membranes.  S som et al. reported that simulated annealing
via restrained molecular dynamics is used to generate ensembles of approximately parallel
helix dimers of alamethicin and alamethicin derivative in which all Aib residues are
replaced by Leu to investigate possible effects of Aib residues on helix-helix packing [19].
This substitution has effect on helix-helix packing, indicating that Aib residues affect the
interactions of helices as Leu residues.  Rather, such interactions appear to be sensitive to
interactions between polar side chains.  This simulation supported that some residues
replaced by Aib residues are expected to enhance the ion channel activity.  Actually,
changing only three Leu residues per helix to Aib in (LSLLLSL)3 [to (LSLBLSL)3]
resulted in alterations to both the conductance and the lifetime of channels [20].
Jelokhani-Niaraki et al. reported that all D-amino acid residues in gramicidin B replaced by
Aib residues were increased the conductance of the native gramicidin B [21]. 
The fluorescence quenching studies of Trp residue revealed that [W12]BKBA-20
was deeply buried in the hydrophobic region of lipid membranes as compared to
[W12]AKAA-20.  Moreover, [W12]BKBA-20 had a high affinity with membranes
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[Chapter 2].  These results indicated that the Aib residues in channel peptides contributed
to the stability of self-associated helical structures and the high affinity of peptides for
phospholipid membranes. 
Relationship between the Position of Aib Residues and Biological Activity—Ala-
substituted BKBA-20 analogs, BKAA-20 and AKBA-20 were synthesized, and compared
to BKBA-20 to investigate the effects of the position of the Aib residues for biological
activities.  In these peptides, the total number of the Lys residues, and therefore the
overall positive charge of the peptides, were preserved.  Moreover, BKAA-20 and
AKBA-20 shared a similar number of Aib residues.  Interestingly, the position of Aib
residues in BKAA-20 and AKBA-20 affected their antimicrobial and ion channel activities.
Studies of structure-activity relationships of antimicrobial peptides have shown that
structural parameters such as helical content, hydrophobicity, amphipathicity and peptide
charge are important for antimicrobial activity.  CD spectroscopy revealed that the helix
forming propensities of BKAA-20 and AKBA-20 were independent of the position of Aib
residues in negatively charged phospholipid vesicles, as mimics of the external cell
membranes of bacteria [Chapter 3].  It was also indicated that introduction of Aib
residues into peptide backbone not only promotes the generation of stable helical
conformations, but also modulates the antimicrobial and ion channel activities.  Peptides
of the same amino acid composition as channel-forming peptides (non Aib-peptides) but
with scrambled sequence did not exhibit ion channel activities [15].  It s suggested that
the change of the position of amino acids may change the amphipathic secondary structure
of the peptides, which is considered to be one of the important factors in the activity.
However, to our knowledge, the role of the relative position of Aib residues on the
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antimicrobial activity has not been so far reported.  This r sult is a new knowledge about
the role of Aib residue for the biological activity.  This is an interesting and important
finding that can be utilized in the design of novel helical antimicrobial peptides possessing
high therapeutic potencies. 
Tryptic digestion assay showed that the introduction of Aib residues at P1’
positions into peptide backbone (AKBA-20) increased the digestic resistance than the
introduction of Aib residues at P2 positions (BKAA-20).  Alternately arranged Aib
residues in peptides (BKBA-20) as peptaibols resulted in a completely resistance [Chapter
4].  The results are to be utilized in the rational design and synthesis of rational peptide
antibiotics with increased protease resistances without decreasing the biological activity.
Some enzymes such as alamethicin synthase and a , a -di lkylglysine decarboxylase were
found from fungi and soil bacterium [22, 23]. However, detailed mechanism of the
enzymes and their primary structure remains unclear. Peptaibols (alamethicin,
ampullosporin A, bergofungious and chrysospermin A) also represent a novel and powerful
class of elicitors that can induce multiple metabolic activities such as ethylene emission,
biosynthesis of volatile substances, and tendril coiling [24, 25].  In contrast, similar
channel-forming peptides (non Aib-containing peptides), melittin and valinomycin, had no
metabolic activity [24].  These reports are expected to present a receptor of peptaibol for
the release of elicitors.  These enzymes are of interest to explore the role of Aib residue
for the biosynthesis, metabolic systems and biological activity. 
87
5-3. Conclusion
It was found that the Aib residues in channel peptides contributed to the stability
of self-associated helical structures and the high affinity of the peptides for phospholipid
membranes.  Moreover, introduction of Aib residues into peptide backbone not only
promotes the generation of stable helical conformations, but also modulates the
antimicrobial activity and ion channel activity.  An analog of BKBA-20, BKAA-20, had
considerable antimicrobial activity, but was not hemolytic.  In addition, the position of
Aib residue in peptide backbone affected the resistance to protease digestion, and
alternately arranged Aib residues in peptides resulted in a completely resistance.  Result
of this work can implicate a deeper understanding of the role of Aib residues in structure-
activity relationships of helical channel forming peptides, which in turn promotes the
rational design of effective biological active peptides.
In this work, new biological roles of the simple a , a  -dialkyl amino acid, Aib, was
revealed.  Other natural a , a  -dialkyl amino acids such as isovaline (Iva), as well as
several synthetic a , a  -dialkyl amino acids, have been also reported.  The biological
functions of these amino acids have attracted much interest in recent years.  Moreover,
Aib is an achiral amino acid.  In contrast, Iva is a chiral amino acid.  A question is why
do peptaibols also contain an unusual chiral amino acid?  Recently, Iva were found in a
meteorite. It has been suggested that Iva can be an important molecule for the origin of an
asymmetric molecule [26].  Therefore, a , a  -dialkyl amino acids are required amino acids
in natural products.  Further studies of a , a  -dialkyl amino acids-containing peptides are
in progress in our laboratories. 
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APPENDIX
A-1. Patch-Clamp Measurement
In this technique [1], a clean glass pipette with a tip diameter of about 1 m m is
pressed against an intact cell to form a seal.  Slight suction leads to the formation of a
very tight seal so that the resistance between the inside of the pipette and the bathing
solution is many gigaohms.  Thus, a gigaohm seal ensures that an electric current flowing
through the pipette is identical with the current flowing through the membrane covered by
the pipette. 
A special version of the patch-clamp is the so-called pipette-dipping technique,
used for reconstitution of ion channels in phospholipid bilayer [2].  In this method, a
monolayer of lipid solutions in volatile organic solvents, such as pentane or hexane, is
spread on an aqueous surface.  Th n by redipping of a pre-dipped micropipette in the
solution a bilayer of high electric resistance (2–20 gigaohm) is formed (Fig. A-1).
2
3
1
pipette tip
Bath solution
reference
electrode
patch
electrode
patch pipette (f) =1 m m
current conducting fluid
Mesuring device with 
constant transmembrane 
voltage and amplification 
of current flow across the 
membrane patch
A B
Fig. A-1. Schematic presentation of the experimental apparatus for the pipette-dipping
technique (A) and formation of a planar bilayer at tip of a glass micropipette through a
three step procedure (B).
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A-2. Helix-Bundle Model (Barrel-Stave Model)
In this model [3, 4], a transmembrane channel is assumed to be composed of a
bundle of helical structures which are long enough to span the membrane (Fig. A-2).  The
model considers the diffusion of ions through an inflexible rigid structure of the helix-
bundle.  Schematic presentation of a pentameric helix-bundle pore and its cross-section is
shown in Fig. A-2.  Assuming the cylindrical pore as a conducting structure (surrounded
by bulk solution electrolytes on the two sides of a membrane) which obeys Ohm's law, we
can calculate the pore's resistance by integrating the resistance along the path of the current
flow through it.  In the case of a cylinder the resistance is
Rpore = l / r
2
where  stands for the bulk solution resistivity, l is for the length of the pore and  is for its
radius.  A further resistance of the pore is termed as “access resistance”, which is the
resistance along the convergent paths from the bulk medium to the mouths of the pore, is
calculated to be
Raccess = / 2 r
and
Rtotal = Rpore
 
+ Raccess
considering these equations the conductance (G) of th  pore (or channel) is :
G = 1/Rtotal = r
2/  ( l + r/2)
Through geometrical calculations the radius (r) of the pore can easily calculated
(see the cross-section of the pore in Fig. A-2).  By taking R for the radius of the
monomeric helix, the pore radius can be calculated as
r = R [ 1/sin ( /N ) – 1]
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where N is the number of helix monomers in the bundle.
The approximations made in this treatment of channel conductance are radical, as
they ignore all interaction between the ion and channel, but they allow one to obtain an
upper limit for the conductance of a channel of dimensions equivalent to the cylindrical
volume occupied by a single a -helix crossing a bilayer.  Channel-ion interactions would
thus be expected to results in a conductance of less than above Rpore.  
Theoretical conductances for various values of N were calculated for channel-
forming peptide in accordance with the above considerations.  To our understanding,
following parameters and bulk solution resistivities are commonly used for this model.
l : 30 nm; 1.5 [nm/residue] × (number of residues), as a complete a -helix
R : 0.5 nm,   : 0.13 W m
Fig. A-2.  Schematic presentation of the helix-bundle model: cutaway profile of a
pentameric pore in the membrane (left) and its cross-section (right).
r
R
l
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